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Introduction: Catecholamines such as dopamine are found throughout the mammalian 
reproductive system, where they are hypothesized to play some role in fertilization. A 
dopaminergic phenotype has been discovered in the male spermatozoan of many mammalian 
species. Dopamine regulates a wide range of functions including capacitation, and the  
induction of sperm motility and the acrosome reaction through mechanisms involving 
dopamine receptor (D2) activation. A dose-dependent response to dopamine has been 
observed in sperm, whereby low concentrations were shown to be protective and high 
concentrations were observed to negatively impact sperm functions. This biphasic effect can 
only be explained by the existence of a transporter protein; however, the Dopamine 
Transporter (DAT) is yet to be well explored on human sperm membranes. 
Objectives: To identify DAT on human sperm membranes and determine the effects of 
dopamine, at high, medium, and low concentrations, on human sperm parameters. 
Methods: Utilizing an indirect immunofluorescence assay, spermatozoa were stained with a 
primary anti-DAT antibody against the fluorescent secondary Alexa Fluor® 488. Fluorescence 
was visualized on a confocal microscope. Western blot analyses were employed as a second 
assay to show the presence of DAT on human sperm membranes with rat brain tissue used 
as a positive control. The membranes were exposed to anti-DAT primary antibody against a 
Horseradish Peroxidase (HRP)-linked secondary antibody. Furthermore, the effect of 
dopamine on sperm parameters, at different dopamine concentrations were tested for three 
time periods (0, 1, 3 and 6 hours). Sperm were exposed to high (1 mM), medium (10 μM) and 
low (100 nM) dopamine concentrations at 37°C for 1, 3 and 6 hours,  thereafter functional 
sperm parameters were analysed. Using CASA and the SCA® software system, total motility, 
progressive motility, and sperm kinematics were analysed. Sperm viability and the acrosome 
reaction were additionally assessed. 
Results: The immunofluorescence assay indicates a strong immunoreaction in the positive 
controls vs. the negative controls and it could conclude that DAT is positively expressed on 
human sperm membranes. Western blot analyses further confirmed the existence of DAT in 
human sperm membranes when compared to the positive brain controls. Protein bands of 62 
kDa and 48 kDa appear in the Western Blot lanes loaded with sperm samples, thereby 
positively correlating with bands found in the brain tissue. High concentrations of dopamine 
were found to negatively affect motility parameters as early as 60 minutes (43.05% ± 12.72 vs. 
18.75% ± 8.75). Sperm kinematics were also negatively affected by the addition of high 
concentrations of dopamine when compared to the controls. Sperm viability was significantly 
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decreased by high dopamine concentration after 3 hours of incubation (51.86% ± 7.220 vs. 
34.36% ± 13.03). The high concentration of dopamine was found to elicit a premature 
acrosome reaction upon addition of treatment (26.88% ± 3.199 vs. 31.91% ± 2.85). 
Conclusion: It can be concluded that DAT is found on human sperm membranes and that 
dopamine regulates sperm functions through mechanisms involving the dopamine D2 receptor 
and DAT. These findings suggest a possible regulatory role for DAT inhibitory drugs such as 
















Inleiding: Katekolamiene soos dopamien kom dwarsdeur die voortplantingstelsel van 
soogdiere voor, waar hulle veronderstel is om 'n rol in bevrugting te speel. 'n Dopaminerge 
fenotipe is in die spermatozoë van baie soogdierspesies ontdek. Dopamien reguleer 'n wye 
verskeidenheid funksies, insluitend kapasitering, en die induksie van spermmotiliteit en die 
akrosoomreaksie deur meganismes wat dopamienreseptoraktivering (D2) insluit. 'n 
Dosisafhanklike reaksie op dopamien is waargeneem in sperma, waardeur lae konsentrasies 
beskermend is en hoë konsentrasies spermfunksies negatief beïnvloed. Hierdie bifasiese effek 
kan slegs verklaar word deur die bestaan van 'n vervoerderproteïen; die Dopamien-vervoeder 
(DAT) moet egter nog goed ondersoek word op menslike spermmembrane. 
Doelstellings:  Om DAT op menslike spermmembrane te identifiseer en die effek van 
dopamien  teen hoë, medium en lae konsentrasies op menslike spermparameters te bepaal. 
Metodes: Met behulp van 'n indirekte  immunofluoressensie toets is spermatozoa gekleur met 
'n primêre anti-DAT-teenliggaam teen die  fluoresserende sekondêre Alexa Fluor® 488.  
Fluoressensie is in 'n konfokale mikroskoop gevisualiseer.  Western Blot ontledings is gebruik 
as 'n tweede toets om die teenwoordigheid van DAT op menslike spermmembrane met 
rotbreinweefsel as 'n positiewe kontrole te toon. Die membrane is blootgestel aan anti-DAT 
primêre teenliggaam teen 'n Horseradish Peroxidase (HRP)-gekoppelde sekondêre 
teenliggaam. Verder is die effek van dopamien op spermparameters by verskillende 
dopamienkonsentrasies vir drie tydperke (0, 1, 3 en 6 uur) getoets. Sperma is gedurende 1, 3 
en 6 uur aan hoë (1 mM), medium (10 μM) en lae (100 nM) dopamienkonsentrasies by 37 ° C 
blootgestel, waarna funksionele spermparameters geanaliseer is. Met behulp van CASA en 
die SCA® sagtewarestelsel is totale beweeglikheid, progressiewe beweeglikheid en 
spermakinematika geanaliseer. Daarbenewens is die lewensvatbaarheid van die saad en die 
akrosoomreaksie beoordeel. 
Resultate: Die  immunofluoressensie toets dui op 'n sterk immuunreaksie in die positiewe 
kontroles teenoor die negatiewe kontroles, en  dit kan aflei dat DAT positief tot uitdrukking kom 
op menslike spermmembrane. Western Blot ontledings het die bestaan van DAT in menslike 
spermmembrane bevestig in vergelyking met die positiewe breinkontroles. Proteïenbande van 
62 kDa en 48 kDa verskyn in die Western Blot-bane gelaai met spermmonsters, wat sodoende 
positief korreleer met bande wat in die breinweefsel voorkom. Daar is gevind dat hoë 
konsentrasies dopamien beweeglikheidsparameters negatief beïnvloed al in 60 minute 
(43,05% ± 12,72 teenoor 18,75% ± 8,75). Sperma-kinematika is ook negatief beïnvloed deur 
Stellenbosch University  https://scholar.sun.ac.za
vi 
 
die toevoeging van hoë konsentrasies dopamien in vergelyking met die kontroles. Sperma-
lewensvatbaarheid is aansienlik verminder deur hoë dopamienkonsentrasie na 3 uur inkubasie 
(51,86% ± 7,220 versus 34,36% ± 13,03). Daar is gevind dat die hoë konsentrasie dopamien 
'n voortydige akrosoomreaksie uitlok by toevoeging van die behandeling (26,88% ± 3,199 
versus 31,91% ± 2,85). 
Gevolgtrekking: Daar kan tot die gevolgtrekking gekom word dat DAT op menslike 
spermmembrane voorkom en dat dopamien spermfunksies reguleer deur meganismes wat die 
dopamien D2-reseptor en DAT insluit. Hierdie bevindings dui op 'n moontlike regulerende rol 
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1.1  Introduction and Rationale 
Dopamine is a known neuromodulator within the brain, however its effects outside the central 
nervous system (CNS) are not well studied. Dopamine has been postulated to influence 
reproductive behaviours in mammals, but its direct effect on fertility is not clear. 
Catecholamines such as dopamine and norepinephrine have been found in high 
concentrations within the reproductive tract of mammals such as rats, cows, boars, and 
humans. In females, differential expression of dopamine has been observed throughout the 
oviduct and a dopaminergic phenotype has been established in males. The recent 
identification of the dopamine receptor 2 (D2), on sperm membranes has prompted 
investigations into the effects of agonists and antagonists of this receptor on sperm functions. 
Dopamine, the principle D2 receptor agonist, was found to modulate several sperm functional 
parameters (Otth et al., 2007; de Angelis et al., 2016) including capacitation, motility, and the 
acrosome reaction. The mechanisms through which dopamine brings about changes in these 
sperm parameters is thought to be through dopamine receptor activation. A dose-dependent 
effect has subsequently been observed in boar spermatozoa, whereby low concentrations was 
shown to be protective and high concentrations of dopamine negatively impacted on sperm 
parameters (Ramírez et al., 2009). This effect could be explained by the presence of 
monoamine transporters,  that function to remove catecholamines when an excess is detected. 
Recently Urra and colleagues discovered the presence of monoamine transporters in equine 
sperm, namely norepinephrine transporter (NET), serotonin transporter (SERT) and dopamine 
transporter (DAT) (Urra et al., 2014). Equine spermatozoa were found to express functional 
DAT’s and exposure to dopamine was shown to negatively impact sperm parameters as 
previously described by Ramírez and colleagues (Urra et al., 2014). The biphasic effect of 
dopamine on sperm functions was demonstrated in various mammalian species including 
humans, however DAT is yet to be well explored on human sperm membranes. Considering 
the negative effects exerted by high doses of dopamine on sperm parameters, it is crucial to 
establish the presence of this transporter on human sperm membranes in order for the 
mechanism of dopamine handling by the reproductive system to be further illuminated. 
 
1.2  Problem Statement 
The dopamine pathway is involved in the modulation of sperm parameters however, the effects 
of dopamine on human sperm parameters are yet to be established and the presence of DAT 
on human sperm membranes needs to be further investigated.  
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1.3  Research Question 
Are DATs present on human sperm membranes and what are the effects of different 
concentrations of dopamine on human sperm parameters? 
1.4  Aims and Objectives 
This study was divided into two parts based on the independent aims. 
Aim 1 
To purely identify and localize the DAT protein in human spermatozoa. 
Objectives 
i) Utilize Immunofluorescence (IF) to visually identify DAT protein on human sperm 
membranes. 
ii) Use western blotting (WB) techniques to further confirm the identification of the DAT 
protein in human spermatozoa. 
Aim 2 
To determine the effects of various concentrations of dopamine on human sperm parameters. 
Objective 
Incubate spermatozoa with low (100 nM), medium (10 μM) and high (1 mM) concentrations of 
dopamine for 1, 3 and 6 hours. Investigate the effect of the dopamine concentrations on various 
functional parameters including, total motility, progressive motility, sperm kinematics, viability, 
and acrosome reaction. 
1.5 Thesis Layout 
This thesis comprises of an extensive literature review (Chapter 2) which explores the 
current knowledge regarding dopamine transporters, receptors, as well as the effect of 
dopamine on male reproductive parameters. Following this Chapter 3 will detail the materials 
and methods employed during the study. Chapter 4 will report the results of this study and 
Chapter 5 will discuss and interrogate these results. Finally, Chapter 6 will comprise of the 
conclusion of the study.






Fertilization of gametes is essential for the continuation of any species (Litscher and 
Wassarman, 2006). It is a complex process controlled by a great number of components. The 
main goal is for the spermatozoa to reach the ovum to begin the fertilization process, however 
there are many factors which influence this and may hinder the spermatozoan from reaching 
its goal. 
Infertility is defined as the inability to conceive after 12 months of regular unprotected sexual 
intercourse (Gnoth et al., 2005; WHO, 2010; Du Plessis, 2016; Starc et al., 2019). Male factor 
infertility is said to account for 50% of all infertility cases and approximately 10-15% of men 
suffer from idiopathic infertility (Kothandaraman et al., 2016). In recent years, a significant 
downward trend in male fertility was observed (Kumar and Singh, 2015; Levine et al., 2017). 
A wide range of factors may contribute to male infertility, such as stress, genetics, 
environmental factors, and improper sperm functioning.  
Dopamine is an important catecholamine, which functions as a neuromodulator and 
participates in many biological functions within the body- such as motor control, cognitive 
function, and reproductive behaviours (Daly and Salloway, 1994; Klein et al., 2019). Outside 
of the central nervous system (CNS) dopamine is also located in peripheral tissues, where it 
functions as a local paracrine messenger, vasodilator as well as a modulator of food intake by 
regulating glucose homeostasis (Missale et al., 1998; Rubí and Maechler, 2010). 
Catecholamines, such as dopamine and norepinephrine have additionally been found in high 
concentrations within the reproductive tracts of mammals. This discovery led to the 
investigation into whether a catecholaminergic phenotype existed in the reproductive systems 
of mammals (Otth et al., 2007; de Angelis et al., 2016). Dopamine receptors were subsequently 
shown to be expressed throughout the male reproductive tract and dopamine was shown to 
modulate sperm functions in a dose-dependent effect (Otth et al., 2007; Ramírez et al., 2009). 
Low concentrations were shown to render sperm protection while high concentrations 
impacted negatively on sperm functions such as motility and acrosomal integrity. This biphasic 
effect could only be attributed to the presence of a transporter protein (Ramírez et al., 2009; 
Urra et al., 2014). 
Dopamine receptors have been located on mammalian spermatozoa, including humans, and 
recently a functional dopamine transporter protein (DAT) has been found in equine 
spermatozoa (Ramírez et al., 2009; Urra et al., 2014). These authors also demonstrate that 
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DAT may be located on human sperm membranes and speculate that dopamine may modulate 
sperm parameters by mechanisms involving DAT (Ramírez et al., 2009; Urra et al., 2014). 
This literature review will, therefore, define what dopamine is and how it functions; as well as 
outline the structure and functional relationships that exist between dopamine and its 
receptors. An in-depth analysis of DAT and how its structure relates to its functionality will be 
explored; and the effect of dopamine on the male reproductive system will be examined, 
specifically sperm parameters. 
 
2.2 Dopamine 
Catecholamines are chemicals released by the brain which transfer signals and act as 
hormones that regulate various physiological functions in the CNS (Laverty, 1978; Gnegy, 
2012; Paravati and Warrington, 2019). Dopamine, also known as 3,4-
dihydroxyphenethylamine, is the most prominent catecholamine neurotransmitter in the 
mammalian brain (Klein et al., 2019). Dopamine participates in numerous biological processes 
including the control of cognition, emotion, food intake and endocrine regulation (Missale et 
al., 1998). Dopamine is further characterised as a monoamine neurotransmitter, which are 
neuromodulators containing one amino group connected to an aromatic ring by a two-carbon 
chain (Yousuf and Kerr, 2016). Dopamine is produced in several areas of the brain, including 
the substantia nigra, the ventral tegmental area (VTA) and the hypothalamus, as seen in figure 
1. The substantia nigra, a pigmented streak within the brain forms part of the basal ganglia 
and consists of three sub-regions, the pars compacta, the pars reticulata and the pars lateralis 
(Murray et al., 2019). The substantia nigra contains a cluster of neurons that are involved in 
the regulation of motor movements (Kaufman and Milstein, 2013). The substantia nigra pars 
compacta (SNc)  is the dopamine-containing region where neurons which produce this 
neurotransmitter project to the striatum and release the dopamine to various postsynaptic 
targets in this region of the brain. The striatum is the site of control for motor behaviour; the 
ability of the dopamine system to modulate neuronal interactions within this area is crucial to 
the normal functioning of the basal ganglia system (Albanese, Altavista and Rossi, 1986; 
Chinta and Andersen, 2005; Grace, 2008; Scarr et al., 2013; Murray et al., 2019). Two neural 
pathways, the mesolimbic and mesocortical pathways, originate in the VTA and are 
respectively involved in- reward and pleasure, and cognition and emotion (Wise, 2004; Scarr 
et al., 2013; McHugh and Buckley, 2015).The hypothalamus is the site of origin of 
dopaminergic neurons which control the tuberoinfundibular pathway, a pathway which controls 
hormone secretion and regulation from or by the pituitary gland (Albanese, Altavista and Rossi, 
1986; Scarr et al., 2013; McHugh and Buckley, 2015). 




Figure 1: Dopaminergic pathways in the human brain. (Adapted from Scarr et al., 2013; Felton, 
O’Banion and Maida, 2015). 
The loss of innervation of the dopamine neurons by degeneration or any mechanism which 
impedes the pathway to any extent, could lead to severe cognitive deficits and movement 
disorders (Chinta and Andersen, 2005; Grace, 2008). It is for this reason that the dopaminergic 
system has become a focal point in research for the past 30 years. The dysregulation of the 
dopamine pathway has since been implicated in several pathological conditions such as 
Parkinson’s disease (PD), schizophrenia, hyperprolactinemia, drug addiction and attention-
deficit hyperactivity disorder (ADHD) (Sotnikova et al., 2006; Best, Nijhout and Reed, 2009; 
Rondou, Haegeman and Van Craenenbroeck, 2010).  
 
2.2.1 The synthesis and actions of dopamine 
The synthesis of catecholamines such as dopamine, epinephrine and norepinephrine are 
regulated by the rate-limiting enzyme Tyrosine Hydroxylase (TH) (Daubner, Le and Wang, 
2011; Juárez Olguín et al., 2016). Dopamine synthesis as seen in Figure 2, starts with the 
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amino acid Phenylalanine which is converted to Tyrosine through the phenylalanine 
hydroxylase enzyme. TH then converts Tyrosine to levodopa or L-3,4-dihydroxyphenylalanine 
(L-DOPA), a step which is subsequently followed by the conversion of L-DOPA to Dopamine 
via, aromatic amino acid decarboxylase (AADC), the L-DOPA decarboxylase enzyme 
(Kaufman and Milstein, 2013).  
 
Figure 2: Synthesis of Dopamine (Adapted from Kaufman and Milstein, 2013). 
 
After dopamine is synthesized, it is packaged into vesicles by vesicular monoamine 
transporters (VMATs), specifically VMAT2, which are integrated membrane proteins found on 
synaptic vesicles of presynaptic neurons as seen in figure 3 (Miller et al., 1999; Best, Nijhout 
and Reed, 2009; Juárez Olguín et al., 2016). These vesicles are stored in presynaptic neurons 
and await a stimulus for them to be transmitted across the synapse, whereafter the release of 
dopamine occurs through exocytosis (Agnati et al., 1995; Juárez Olguín et al., 2016). Once 
dopamine is released into the extracellular space (synaptic cleft) it can bind to metabotropic 
receptors located on postsynaptic targets or presynaptic auto receptors (Kandel et al., 2000). 
After dopamine has bound to its extracellular targets and elicited its effect, the neurotransmitter 
quickly becomes unbound (Floresco et al., 2003). The ‘free’ dopamine is now removed from 
the extracellular space and sequestered back into presynaptic cells to be recycled by a process 
mediated by the Dopamine Transporter (DAT) (Miller et al., 1999; Schmitt, Rothman and Reith, 
2013; McHugh and Buckley, 2015; Klein et al., 2019). As previously mentioned, dopamine 
functions as both a hormone and a neurotransmitter (Danborg, Simonsen and Gotzsche, 
2017). Consequently, dopamine acts as a neuromodulator, rather than a catecholamine that 
simply excites or inhibits targets, therefore signalling cascades are triggered by the modulation 
of synaptic transmission (Rondou, Haegeman and Van Craenenbroeck, 2010).  




Figure 3: Release of dopamine at the synapse. (Author’s own illustration) 
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Although this catecholamine has primarily been found in the brain, it has also been located in 
peripheral tissues where it performs several functions including the modulation of 
cardiovascular function, hormone secretion and gastrointestinal motility (Missale et al., 1998). 
Since dopamine does not cross the blood-brain barrier and dopaminergic signalling within the 
CNS is functionally distinct from peripheral pathways, where would the dopamine found in 
these peripheral tissues arise from? Dopamine that has been found in peripheral tissues such 
as the kidney, liver, and heart, can originate from three different sources namely neuronal 
fibres, adrenal medulla, and neuroendocrine cells. Dopamine synthesis is therefore, both 
dependent and independent of neuronal elements (Rubí and Maechler, 2010). These 
neuroendocrine cells, called amine precursor uptake and decarboxylation (APUD) cells can 
produce and store biologically active neurotransmitters, by converting amino acid precursors 
(Norris and Carr, 2013). APUD cells have been found in the kidney, both the endocrine and 
exocrine pancreas and retinal cells (Wahbe et al., 1982; Mappouras, Stiakakis and Fragoulis, 
1990; Mezey et al., 1996; Rubie et al., 2001; Kubrusly et al., 2008).  
Vascular endothelial cells can  produce dopamine, dopamine lowers blood pressure by 
stimulating cardiac contractility, which subsequently induces vasodilation in coronary vascular 
beds (Amenta et al., 2002). Dopamine also acts as a natriuretic hormone by increasing the 
excretion of sodium in the urine thereby modulating the sodium balance and maintaining blood 
pressure (Rubí and Maechler, 2010). The dysregulation of dopamine-dependent mechanisms 
has therefore been implicated in the pathogenesis of hypertension (Zeng et al., 2007). 
Dopamine indirectly modulates food intake and plays a role in the regulation of glucose 
homeostasis as well as body weight (Rubí and Maechler, 2010; Timper and Brüning, 2017). 
Once the hypothalamus releases dopamine, it tonically inhibits the secretion of prolactin from 
the pituitary and prolactin is required for the proliferation of β-cells of the pancreas and 
subsequently insulin secretion (Brelje, Parsons and Sorenson, 1994; Hügl and Merger, 2007; 
Auffret et al., 2013). Additionally, the pancreatic β-cells also exhibit a dopaminergic phenotype, 
allowing dopamine, through the effects of metabotropic dopamine receptor D2, to actively 
inhibit insulin secretion (Rubi et al., 2005). It is also assumed that the dopamine secreted into 
the small intestine, originates from the exocrine pancreas, and reduces gastrointestinal motility 
(Rubí and Maechler, 2010).  
2.3 Dopamine Receptors 
Dopamine is known to exert its modulatory effects through the binding and activation of 
metabotropic receptors (Seeman, 2010; Klein et al., 2019). The earliest evidence of the 
existence of dopamine receptors came in 1972 when it was revealed that dopamine was able 
to stimulate the second messenger protein adenylyl cyclase (AC). In 1976 Alexander Rudolf 
Cools was the first person to propose the existence of multiple dopamine receptors (Cools and 
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Van Rossum, 1976). Earlier terms used to identify different types of dopamine receptors were 
alpha (α)- and beta (β)-dopaminergic receptors (Kebabian, 1978), although these terms are 
no longer in use since they were most easily confused with the α- and β-adrenoceptors 
(Kebabian and Calne, 1979). In 1979 Kebabian and Calne found that the actions of dopamine 
were mediated by two dopamine receptors - D1 and D2. In mammals, five subtypes of 
dopamine receptors have been identified, namely D1, D2, D3, D4 and D5. In humans, 
dopamine expresses a high binding affinity for these receptors, as well as for an additional 
receptor - Trace Amine-Associated Receptor 1 (TAAR1) (Seeman, 2010; Beaulieu, Espinoza 
and Gainetdinov, 2015; Bhatia and Saadabadi, 2019). The five subtypes of dopamine 
receptors can be divided into two families, namely D1-like and D2-like, based on their 
interaction with AC (explained later in the text) (Kebabian and Calne, 1979). The two families 
also differ in their binding profile and physiological effects (Weng, Li and Hsu, 2017). D1-like 
receptors are composed of the D1 and D5 receptors, whereas D2-like receptors are composed 
of the D2, D3 and D4 receptors (Mishra, Singh and Shukla, 2018). Dopamine receptors are 
found throughout the CNS and the relative density of the receptors are D1 > D2 > D3 > D5 > 
D4 (Missale et al., 1998; Mishra, Singh and Shukla, 2018).  
 
2.3.1 Dopamine Receptor structure 
Dopamine receptors are seven transmembrane (TM) G protein-coupled receptors (GPCR). 
GPCRs form part of a huge superfamily of integral proteins which are membrane spanning. 
They are activated by extracellular ligands, and upon activation, pass signals to the cell interior 
via signal transduction pathways (Missale et al., 1998; Bhatia and Saadabadi, 2019). Ligands, 
such as dopamine, may bind either to the extracellular N-terminus and loops or within the 
transmembrane helices (Trzaskowski et al., 2012; Bhatia and Saadabadi, 2019). Structurally 
the extracellular N-terminus is connected to seven TM α-helices, which are made up of three 
extracellular and three intracellular loops, and a cytoplasmic C-terminus (Bhatia and 
Saadabadi, 2019). There are many similarities and differences between the D1-like and the 
D2-like receptors (Civelli, Bunzow and Grandy, 1993; Gingrich and Caron, 1993; O’Dowd, 
1993; Jackson and Westlind-Danielsson, 1994). The D1 and D5 receptors share 80% 
homology in their TM domains, the D2 and D3 receptors share 75% homology in their TM 
domains and the D2 and D4 share 53% homology in their TM domains (Civelli, Bunzow and 
Grandy, 1993; Gingrich and Caron, 1993; O’Dowd, 1993; Jackson and Westlind-Danielsson, 
1994). The D1 and D5 receptor subtypes each possess two N-linked glycosylation sites 
whereas the D2 receptor contains four such sites, the D3 has three, and the D4 possesses 
only one such site (Missale et al., 1998). N-linked glycosylation is the attachment of an 
oligosaccharide or glycan to the nitrogen atom on the asparagine (N) residue of a protein - this 
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process is enzyme catalysed and can influence the protein folding or the stability of the 
glycoprotein it is coupled to (Imperiali and O’Connor, 1999; Ranganathan, Wongsai and 
Helena Nevalainen, 2006). In the D1-like receptor family the COOH terminal is about seven 
times longer than that of the D2-like receptors (Civelli, Bunzow and Grandy, 1993; Gingrich 
and Caron, 1993; O’Dowd, 1993; Jackson and Westlind-Danielsson, 1994). Both the D1-like 
and the D2-like receptors express two cysteine residues in extracellular loops 2nd and 3rd, which 
has been suggested to act as a stabilizer by forming a disulphide bridge (Fraser, 1989; 
Dohlman et al., 1990). 
 
2.3.2 Dopamine Receptor function and mechanism of action 
Dopamine receptors regulate many functions in the human body, in particular motor and non-
motor functions (Mishra, Singh and Shukla, 2018). The effects of these receptors occur via 
signal transduction pathways and are mediated by the type of dopamine receptor activated. 
The two families of dopamine receptors, although all GPCRs, have different mechanisms of 
action. Once activated by ligands, these receptors undergo a conformational change to an 
active state - the receptor then reorientates the side chains of amino acids within the TM 
domain, causing a conformational change for G protein recruitment to the intracellular side 
(Trzaskowski et al., 2012; Weng, Li and Hsu, 2017). The primary distinction between the two 
dopamine receptor families is the positive and negative coupling to AC, where D1-like 
receptors increase the level of cyclic adenosine monophosphate (cAMP) by activating AC and 
D2-like receptors decrease the level of cAMP by inhibiting AC (Missale et al., 1998). Once a 
ligand binds, guanosine nucleotide-binding proteins (G proteins) either activate or inhibit AC, 
and in doing so, affect the levels of second messengers, such as cAMP, Diacylglycerol (DAG) 
and Inositol triphosphate (IP₃), produced. 
A pivotal requirement to discern between the individual receptor subtypes’ functions is the 
identification of their agonists and antagonists (Missale et al., 1998; Klein et al., 2019). Both 
receptors in the D1-like family are linked to stimulatory G-proteins and express near identical 
pharmacological profiles, but generally antagonists present a higher affinity for the D1 than for 
the D5 receptor (Tiberi et al., 1991). The D1 receptor is the most abundant dopamine receptor 
in the brain and specifically plays an integral role in the regulation of the reward system, 
memory, attention, and locomotive activity. (Daly and Salloway, 1994; Mishra, Singh and 
Shukla, 2018). Similarly, the D5 receptor regulates cognition, attention and decision making, 
although dopamine was found to have a 10-fold higher affinity for D5 receptors in comparison 
to D1 receptors (Daly and Salloway, 1994; Mishra, Singh and Shukla, 2018). All the D2-like 
receptors are linked to inhibitory G-proteins. D2 regulates learning and memory, as well as 
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sleep and reproductive behaviour (Mishra, Singh and Shukla, 2018). D2 receptors can be 
localized both pre- and post-synaptically and is of particular interest in pharmacological studies 
as it is the main receptor for most antipsychotic drugs (Seeman and Lee, 1975; Creese, Burt 
and Snyder, 1976; Meltzer, Matsubara and Lee, 1989). 
Researchers have found that the D2 receptor exists in two isoforms: the long form (D2L) and 
the short form (D2S) (Daly and Salloway, 1994; Picetti et al., 1997; Mishra, Singh and Shukla, 
2018). The long form functions as a traditional postsynaptic receptor while the short form is 
localized pre-synaptically and acts as an auto receptor, which regulates the levels of dopamine 
in the synaptic cleft (Beaulieu and Gainetdinov, 2011). The long form differs from the short 
form with the insertion of 29 amino acids on the third intracellular loop, the loop at which the 
receptor couples to different G proteins (Picetti et al., 1997). Although found to exhibit minor 
differences in affinities for certain G-proteins (Daly and Salloway, 1994), analysis of their 
pharmacological profiles shows that there are no compounds (agonists and antagonists) which 
discern any differences between the long and short forms of the D2 receptors (Missale et al., 
1998). D2 receptors were shown to undergo homodimerization where TM 4 was the main site 
of interaction (Guo, Shi and Javitch, 2003; Lee et al., 2003). Evidently dopamine has been 
suggested to play a role in cell proliferation control and cell survival via mechanisms involving 
the D2 receptor activation, interestingly as activation of dopamine receptors exerts an inhibitory 
effect on cancer growth (Ishibashi et al., 1994; Rubí and Maechler, 2010). This paradoxical 
effect has previously been observed by endogenous substances, endocannabinoids, by 
binding to cannabinoid CB1 receptors they suppress cancer cell proliferation (De Petrocellis 
et al., 1998; Velasco et al., 2007). Through the mechanism of receptor crosstalk, CB1 and D2 
receptors have been shown to form functional complexes, where they act as heterodimers 
(Kearn et al., 2005; Navarro et al., 2010). The CB1 and D2 receptors are linked to stimulatory 
G proteins and inhibitory G proteins, respectively, thus, the consequence of this interaction is 
the shift of signalling in favour of CB1 receptor signalling, by mechanisms involving 
Extracellular Signalling Kinases (ERK 1/2) (Kearn et al., 2005). 
The D3 and D4 receptors seem to be pharmacologically similar to the D2 receptor and also 
function by inhibiting AC and thereby decreasing the levels of cAMP. However, D3 appears to 
affect AC very weakly (Daly and Salloway, 1994; Missale et al., 1998). D3 receptors are 
generally found in areas of the brain which regulate impulse control, cognition, and locomotive 
activity, which may indicate its mediatory effect on drug-seeking behaviour (Le Foll et al., 
2014). Dopamine was found to have a 20-fold higher affinity for the D3 receptor than the D2 
receptor (Sokoloff et al., 1990). The D4 receptor functions are very similar to the other D2-like 
receptor subtypes- regulation of cognition, impulse control, sleep, and reproductive behaviours 
(Mishra, Singh and Shukla, 2018). 
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2.4 Regulation of Dopamine 
The regulation of dopamine is controlled by several different factors. These include the quantity 
in which it is synthesized and released, the number of dopamine receptors (DR’s) onto which 
dopamine can bind, and the termination of dopamine activity at the synapse via several 
proteins (McHugh and Buckley, 2015). These proteins include Monoamine Oxidase (MAO), 
Catechol-O-methyltransferase (COMT) and Aldehyde Dehydrogenase (ALDH) (Shih and 
Thompson, 1999; Kaufman and Milstein, 2013; Juárez Olguín et al., 2016). MAO has been 
implicated in the pathogenesis of PD. It metabolizes free dopamine within the presynaptic 
neuron to produce highly toxic and reactive oxygen species (ROS) such as hydrogen peroxide 
(H2O2) and 3,4-dihydroxyphenylacetaldehyde (DOPAL) (Doorn et al., 2014). While ALDH is 
responsible for maintaining subcellular homeostasis by metabolizing endogenous and 
exogenous reactive compounds (Wang and He, 2018). It further metabolizes DOPAL to 3,4-
dihyroxyphenylacetic acid (DOPAC) (Doorn et al., 2014). Furthermore, DOPAC is then finally 
metabolized by COMT to Homovanillic Acid (HVA) (Eisenhofer, Kopin and Goldstein, 2004; 
Kaufman and Milstein, 2013). COMT is involved in the inactivation of dopamine by degradation 
mainly in the extracellular space. COMT is of particular interest as there has been much 
controversy regarding the orientation of membrane-bound COMT (MB-COMT) in the CNS 
(Schott et al., 2010; Chen et al., 2011), as well as how its activation pathway is mediated. One 
study performed by Schott et al., in 2010, on cultured neocortical neurons, found that the MB-
COMT was found to be orientated intracellularly. They then suggested that there may be a 
DAT1-independent postsynaptic uptake mechanism for dopamine, prior to its degradation via 
COMT. However, another study has concluded that the catalytic domain of MB-COMT is found 
in the extracellular space, which suggests that MB-COMT may metabolize dopamine 
synaptically and extrasynaptically on the surface of presynaptic and postsynaptic neurons 
(Chen et al., 2011). This suggests that these enzymes not only play a major role in the recycling 
of the individual components of dopamine, but also metabolize dopamine and keep the 
concentration of dopamine lower than the rate at which it is being produced (Shih and 
Thompson, 1999). 
TAAR1 is a GPCR which regulates monoaminergic transmission and exhibits an inhibitory 
effect on dopamine transmission upon stimulation by an agonist (Miller, 2011; Asif-Malik, 
Hoener and Canales, 2017). TAAR1 and dopamine D2 auto receptors are known to form 
heterodimers and therefore modulate dopamine signalling by altering the transport capacity of 
DAT (Harmeier et al., 2015). DAT is responsible for the reuptake of dopamine from the synaptic 
cleft into the presynaptic neuron when an excess of dopamine is detected in the synaptic cleft 
(Schmitt, Rothman and Reith, 2013; McHugh and Buckley, 2015; Klein et al., 2019). DAT is 
therefore the target of addictive drugs such as cocaine, amphetamine (AMPH), 
Stellenbosch University  https://scholar.sun.ac.za
13 
 
methamphetamine (METH) and Ritalin (Vaughan and Foster, 2013) as the inhibition of this 
transporter leads to an accumulation of dopamine at the synaptic cleft, making it more available 
for the downstream effects of DA receptor activation. It is however important to note that 
another protein, the Norepinephrine Transporter (NET), may also be partially responsible for 
some reuptake of dopamine (Horn, 1973; Raiteri et al., 1977), which may have a higher affinity 
for dopamine in some areas of the brain than DAT itself (Giross et al., 1994; Gu, Wall and 
Rudnick, 1994; Eshleman et al., 1999). 
 
2.5 Dopamine Transporter 
As mentioned, DAT is responsible for the reuptake of dopamine from the synaptic cleft into the 
presynaptic neuron. Similar to the dopamine receptor, DAT is an integral protein, spanning the 
plasma membrane where it interacts with extracellular dopamine (Nirenberg et al., 1996). It is 
a Na+ and Cl- dependent transporter which forms part of the solute carrier (SLC) family and is 
denoted as solute carrier 6 member 3 (SLC6A3). DAT forms part of a superfamily of transporter 
proteins called the neurotransmitter transporters (NTT), it displays amino acid homology with 
other neurotransmitter transporters, namely the norepinephrine transporter (NET) serotonin 
transporter (SERT) and gamma (γ)-amino butyric acid (GABA) transporter (Chen and Reith, 
2000; Pramod et al., 2013). It has the highest homology with NET but less so with SERT and 
the GABA transporter. DAT has been localized in areas of the brain with established 
dopaminergic circuitry e.g., mesocortical and mesolimbic pathways (Nirenberg et al., 1996; 
Ciliax et al., 1999). DAT levels in the brain may vary from normal - this could be attributed to a 
range of factors such as - degeneration of dopamine neurons, hyper-innervation of these 
neurons and drug-induced alterations of their neural networks (Miller and Madras, 2002). In 
the mid-1950’s Julius Axelrod was the first to propose that reuptake was an important 
mechanism for the inactivation of neurotransmitters including dopamine. It would take another 
30 years for the genes that encode these transporters, which are responsible for monoamine 
reuptake, to be identified (Torres, Gainetdinov and Caron, 2003).  
 
2.5.1 DAT genetics 
The human DAT gene (DAT1) has been localized on chromosome 5 (Giros and Mestikawy, 
1992; Vandenbergh et al., 1992). This gene spans over 64kB and consists of 15 coding exons 
separated by 14 non-coding introns (Figure 4) (Kawarai et al., 1997). Polymorphisms within 
the DAT gene have been of particular interest through the decades, as heterogeneity in this 
gene may influence the functionality thereof and its expression levels within the brain and other 
organs (Miller and Madras, 2002). These polymorphisms are also thought to be the route of 
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many disorders related to dopamine. On the 3’ Untranslated Region (UTR) of the DAT gene 
lies a variable number of tandem repeats (VNTR) which spans 40-base pairs (Vandenbergh 
et al., 1992; Miller and Madras, 2002). This is the most extensively studied polymorphism within 
the DAT gene, alleles of this VNTR sequence range from 3 to 13 repeats (Bannon et al., 2001). 
Previously differences in the VNTR of the gene have been shown to affect basal levels of 
transporter expression and functionality (Vandenbergh et al., 1992; Miller and Madras, 2002). 
Interesting to note is that as the VNTR lies within the 3’ UTR, a non-coding region, allelic 
variants of the gene should not result in any structural or functional differences within the 
protein. However, it was revealed that VNTR’s can function as transcriptional and translational 
regulators (Nakamura, Koyama and Matsushima, 1998; Mill et al., 2002). Investigations to link 
the number of tandem repeat units to various diseases has led to the revelation that an 
association may exist between VNTR polymorphisms; the 10-repeat length is associated with 
ADHD, whereas the 9-repeat length has been associated with alcohol and nicotine addictions 
(Cook et al., 1995; Muramatsu and Higuchi, 1995; Miller and Madras, 2002). However, a 
systematic review and meta-analysis performed by Tunbridge et al., in 2019 argues against 
any associations between the 3’ UTR VNTR and various disease states. They conclude, from 
their findings, that the VNTR could not play a major role in influencing DAT function (Tunbridge 
et al., 2019). Various single nucleotide polymorphisms (SNP) along with rare conservative 
amino acid substitutions have been identified within the coding region of the human DAT 
(hDAT) gene. However, these were all found to be silent subsequently leading to no change 
in functionality of the protein or its expression (Bannon et al., 2001). Five SNPs were identified 
within the 5’UTR. Investigations have led to the discovery of possible associations between 
these polymorphisms and disease states, such as schizophrenia. However, authors support 
the undertaking of further research to confirm the associations between the polymorphisms 
within this region of the gene and the functional expression of this protein in disease states 
(Sacchetti et al., 1999; Rubie et al., 2001; Stöber et al., 2006).  
 
Figure 4: Schematic representation of the human dopamine transporter gene. Shaded exons in the 
DNA form the coding region, white exons contribute to the 5′ and 3′ non-coding regions. The 3′-
untranslated region of the RNA is derived from a major portion of exon 15 and includes a variable 
number tandem repeat (VNTR) region (stripes) (Miller and Madras, 2002). 
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2.5.2 DAT structure 
The identification of NTTs such as DAT was built on the elucidation of the high-resolution 
structure of a bacterial leucine transporter (LeuT) first identified in 2005 (Yamashita et al., 
2005). Although LeuT and NTTs only possess a 20-25% homology with each other the use of 
LeuT as a structural template for NTTs is fundamental in the understanding of their structure-
function relationships (Kristensen et al., 2011; Pramod et al., 2013). NTTs have been shown 
to be highly homologous and therefore share a comparable general structure (Kristensen et 
al., 2011). Photoaffinity labelling studies show that DAT is a glycoprotein with a molecular 
weight of between 60kDa and 80kDa, when in its native form in neuronal membranes (Sallee 
et al., 1989; Milner, Béliveau and Jarvis, 1994; Chen and Reith, 2000; McHugh and Buckley, 
2015; Foster and Vaughan, 2017). The protein, 620 amino acids in length, is composed of 12 
TM helices, which are connected by alternating extracellular and intracellular loops (Figure 5). 
DAT contains six extracellular and five intracellular loops (Figure 5). TMs 1, 2 and 8 are 
conserved across DAT, NET and SERT (Madras, Miller and Fischman, 2005). The hDAT 
displays a 92% homogeneity with the rat dopamine transporter (rDAT) and an 84% 
homogeneity to the bovine DAT (bDAT) (Giros and Mestikawy, 1992). 
 
 
Figure 5: Simplified model of the Dopamine Transporter (DAT) protein structure. The 12 transmembrane 
(TM)-spanning hydrophobic domains are depicted as blue cylinders, linked by amino acid chains. The 
amino- and carboxyl terminals are located intracellularly, and N-linked glycosylation sites can be located 
within the large second extracellular loop. (Adapted from Madras, Miller and Fischman (2005). 
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Nearly all the TMs in DAT are α-helical except for unwound segments of TM1 and TM6 which 
form the core for the active site of the protein and separate the helices into functional segments 
(Kristensen et al., 2011; Vaughan and Foster, 2013). Several α-helical structures are located 
within the intracellular and extracellular loops while TM helices 1, 3, 6, and 8 form the substrate 
permeation pathway or substrate binding site (S1) (Chen and Reith, 2000; Kristensen et al., 
2011; Vaughan and Foster, 2013). The movement of the substrate i.e., Dopamine is controlled 
by intracellular and extracellular gates situated directly above and below the active site, which 
also dictate the inwardly or outwardly facing conformations of the protein (Vaughan and Foster, 
2013). Two Na+ binding sites, Na1 and Na2, along with a Cl- binding site were located near the 
S1 binding site, supporting the idea that DAT translocates its substrates along with Na+ and 
Cl- ions (Kristensen et al., 2011).  
 In X-ray crystallography studies, LeuT was structurally shown to adopt a unique folding 
pattern. This structural hallmark was critical to understanding how the structure-function 
relationship works and it was dubbed the LeuT fold (Forrest and Rudnick, 2009; Kristensen et 
al., 2011). The LeuT fold is described as an inverted structural repeat, denoted as the ‘5 + 5 
inverted repeat’. DAT was shown to present with the same fold along with many other NTTs 
(Cheng and Bahar, 2015). The 5 + 5 architecture of the LeuT fold reveals that TMs 1-5 and 
TMs 6-10 forms two bundles of 5 helices aligned invertedly to one another (Figure.6). The TMs 
11 and 12 lie on the periphery of the 5 + 5 core and are assumed to play a role in regulation 
but not in transportation of substrates (Forrest and Rudnick, 2009; Kristensen et al., 2011; 
Pramod et al., 2013). It was observed that the inverted repeat structure contributes to the 
functionality of the transporter, as it allows the protein to change conformation (Forrest and 
Rudnick, 2009; Kristensen et al., 2011; Pramod et al., 2013). The LeuT structure identified in 
2005 dictated an extracellularly orientated protein whereby the substrate binding site was only 
accessible from this side of the membrane. However, a model of the LeuT, where the two the 
bundles of TMs helices (1-5 and 6-10) were simply swapped, was generated - this revealed a 
cytoplasmic access pathway to the central binding site and simultaneously the extracellular 
pathway to this site became occluded (Forrest and Rudnick, 2009).  




Figure 6: Schematic of the topology of LeuT with the inner ring (TM1, TM3, TM6, and TM8) that forms 
the substrate binding site shown in blue. The red triangles highlight the 5 + 5 inverted repeats, formed 
by TMs 1 to 5 and TMs 6 to 10, that are related by an apparent two-fold symmetry. (Kristensen et al., 
2011) 
 
Three N-linked glycosylation sites can be localized within the large second extracellular loop. 
The glycosylation sites can undergo phosphorylation and appear to be essential for the 
transport efficiency of DAT, as well as its stable membrane expression (Lin et al., 1999; Li et 
al., 2004; McHugh and Buckley, 2015). Important to note is that microheterogeneity exists 
within DAT, where differences have been observed in the content of the N-linked 
glycosylation sites (Lew et al., 1992; Patel, Uhl and Kuhar, 1993; Vaughan et al., 1996). DAT 
has been shown to be expressed in cells as either a mature or immature protein, the latter 
being either partially glycosylated or non-glycosylated (Daniels and Amara, 1999; Hastrup, 
Karlin and Javitch, 2001). Lew and colleagues have shown that DAT presents as different 
molecular sized proteins in the nucleus accumbens and the striatum of rat brains, with the 
striatum presenting a slightly lower molecular weight band (Lew et al., 1992). In addition to 
the microheterogeneity found within the different regions of a specific target organ (i.e., the 
brain), species-specific differences also exist. These species-specific variances could be 
attributed to the difference in the number of predicted N-linked glycosylation sites between 
rats and humans, for example (Patel, Uhl and Kuhar, 1993; Vaughan et al., 1996). A study by 
Nguyen and Amara demonstrated that N-linked oligosaccharides are required for the cell 
surface expression of monoamine transporter, NET, however they do not influence the 
affinity of substrates or inhibitors for transport by this protein (Nguyen and Amara, 1996). The 
question of whether glycosylation influences DAT function remained. In 2004 Li and 
colleagues demonstrated through site-directed mutagenesis that both glycosylated and non-
glycosylated DAT (mature and immature) appear to be functional (reaches the surface 
membrane), albeit the non-glycosylated form functions at a slightly lower efficiency. The non-
glycosylated DAT was suggested to be more susceptible to proteolytic degradation before 
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being able to reach the surface membrane (Li et al., 2004). N-linked glycosylation regulation 
of DAT might function to facilitate the formation of the homo-and hetero-oligomeric protein 
interactions, however non-glycosylated DAT monomers are still able to form homo-oligomers 
(Hastrup, Karlin and Javitch, 2001; Li et al., 2004). 
Also localized on the second extracellular loop is a disulphide bond, thought to play a role in 
the biosynthesis of the transporter (Chen et al., 2007). Large N- and C- terminal domains are 
located in the cytosol and contain sites for post translational modifications and regulatory 
binding partners such as Syntaxin 1A (Syn1A) and D2 Dopamine Receptors (Vaughan and 
Foster, 2013). Structurally, DAT expresses multiple phosphorylation sites (serine, threonine, 
and tyrosine) in the cytoplasm (Vaughan and Foster, 2013). 
 
2.5.3 DAT function and mechanism of action 
As dopamine is known to be an essential modulatory neurotransmitter, DAT plays a crucial 
role in dopamine homeostasis (McHugh and Buckley, 2015). DAT is a monoamine transporter 
and is responsible for the clearance of dopamine in the synaptic cleft, thereby terminating the 
signal of this neurotransmitter. For decades, the mechanism behind the transport of solutes 
across membranes has been modelled after the alternating access mechanism. In this model, 
solutes can bind to sites on both sides of the membrane as it may undergo conformational 
changes to face inwardly or outwardly; this conformational change allows for alternating 
access to the substrate binding site. (Forrest et al., 2008; Forrest and Rudnick, 2009). Figure 
7 depicts the alternating access mechanism. The alternating access mechanism allows for 
many forms of transport: uniport, displayed by glucose transporters in cells; antiport, where 
solutes are transported across the membrane, but before it can reorientate itself, another 
solute binds and is transported in the opposite direction; symport, which involves the transport 
of solutes across the membrane in the same direction (Forrest and Rudnick, 2009). For a 
conformational change to occur, an intermediate state is likely to exist in transporters. In this 
case, the intermediate state is called the occluded state, where the substrate binding site is 
inaccessible from either side of the membrane, ensuring that the transporter does not become 
a channel through the membrane (Forrest and Rudnick, 2009). 
DAT is a symporter, which couples the movement of dopamine across the plasma membrane 
to the movement of two Na+ ions and one Cl- ion against their concentration gradients. The 
ion-concentration gradient generated by the Na+/K+ ATPase pump is the driving force for DAT-
mediated dopamine reuptake (Torres, Gainetdinov and Caron, 2003). Sodium and chloride 
ions bind to their sites within the transporter, whereafter dopamine binds to S1. Once dopamine 
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binds, the protein undergoes a conformational change, which allows the ions and dopamine to 
dissociate on the other side of the membrane (Forrest and Rudnick, 2009). 
Substrate translocation is tightly controlled and follows a strict set of steps, whereby the 
transporter changes conformation and the substrates dissociate. The rocking bundle 
mechanism has been proposed to account for the transition of the outwardly facing 
conformation to the inwardly facing conformation (Forrest and Rudnick, 2009). TM’s 1 and 6 
form a four-helix bundle along with TM’s 2 and 7 and the remaining TM’s 3, 4, 5, 8, 9 and 10 
form a scaffold around this bundle. The simple rocking of this bundle in relation to the scaffold 
results in the transition between two alternate orientations and would therefore open or close 
the pathway to S1 (Forrest et al., 2008; Forrest and Rudnick, 2009; Pramod et al., 2013). 
Occupation of S1 by the substrate leads to the outwardly facing occluded state whereby the 
substrate is trapped. The protein rearranges to the inwardly facing conformation whereby S1 
is orientated towards the cytoplasm and the substrate dissociates, thus conformational 
changes are under the control of ligand binding (Forrest and Rudnick, 2009; Kristensen et al., 
2011). 
 
Figure 7: Illustration of alternating access and channel modes of transport. Substrate (S) and ions (Na 
and Cl) access the binding site of the outward facing transporter (i) via the open outer gate (black sticks); 
the outer gate closes yielding the occluded state (ii) which then transitions to the inward facing state (iii), 
releasing the substrate and ions to cytosol. The transporter then rectifies to the outward facing structure 
(i). (Adapted from Pramod et al., 2013) 
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Initially literature focused on DAT functioning as a monomer, however recent studies suggest 
that DAT may undergo oligomerization. This may impact upon protein functions by regulating 
protein translocation to the membrane affecting DAT transport efficiency (Pramod et al., 2013; 
Cheng et al., 2019). DAT has subsequently been shown to form dimers, trimers and even 
tetramers via cross-linking, radiation inactivation and co-immunoprecipitation studies (Zhen 
and Reith, 2018). Cross-linking experiments in mouse brain striatal membranes showed that 
DAT may exist as a dimer in the plasma membrane (Hastrup, Karlin and Javitch, 2001). 
Through radiation inactivation studies canine brain striatal membranes yielded protein sizes of 
278±16kDa; this along with other studies is indicative that the neuronal native form of DAT is 
~70kDa and is assembled in a tetramer (Berger et al., 1994; Milner, Béliveau and Jarvis, 1994). 
It was found that DAT possesses two distinct symmetrical interfaces which interact with one 
another to form a dimer of a dimer, or simply a tetramer (Hastrup, Sen and Javitch, 2003). The 
assembly of the monomers of DAT into oligomers was found to play a critical role in the 
functioning and expression of the protein (Torres et al., 2003). DAT oligomers were found to 
cooperate because one protomer can influence the properties of another protomer of DAT 
(Sitte, Schütz and Freissmuth, 2015). The functional role of DAT heterooligomers was 
investigated with cocaine analogues. When DAT contained different combinations of 
promoters with different affinities for inhibitors, only one protomer of an oligomer was found to 
be active at a time, and the binding affinity of a protomer in this organization may be influenced 
by the active protomer. Therefore, the active protomer influences the other protomers affinity 
for inhibitors (Zhen et al., 2015). However, despite the knowledge of cooperativity for inhibitor 
affinity, it was not known whether the oligomeric organization of DAT is required for the proper 
uptake of dopamine or whether the individual protomers function independently to translocate 
dopamine across the plasma membrane (Zhen and Reith, 2018). Zhen and Reith 
demonstrated, through cross-linking agent Copper Phenanthroline (CuP), that only one 
protomer of DAT is active at a time, thus a dimer of DAT functions only at 75% of what a 
monomer (protomer) functions at. Therefore, the oligomeric state of DAT regulates the function 
of the protein (Zhen and Reith, 2018). 
 
2.5.4 DAT Regulation 
DAT protein regulation is well established as it is an important feature for the modulation of 
dopamine clearance (Vaughan and Foster, 2013). The activity of the transporter is regulated 
at post-translational levels. Through various post-translational modifications (PTMs) including 
N-linked glycosylation- PTMs can modulate the rate at which the transporter moves dopamine 
or causes the internalization of the transporter (Torres et al., 2003; Vaughan and Foster, 2013; 
German et al., 2015). DAT may also form protein interactions which are involved in the 
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regulation and trafficking of DAT to the plasma membrane (German et al., 2015). Multiple 
kinases play important roles in the regulation of DAT; these include protein kinase C (PKC), 
Ca2+/calmodulin-dependent kinase II (CaMKII), Mitogen Activated Protein Kinase (MAPK) and 
ERK (Pramod et al., 2013; Vaughan and Foster, 2013) as seen in figure 8. Although multiple 
phosphorylation sites are structurally situated on the intracellular domains, it appears these 
sites are not directly phosphorylated, instead, DAT is phosphorylated at non-consensus sites 
(Chen and Reith, 2000). Many of the DAT regulatory mechanisms overlap, as protein-protein 
interactions often result in PTMs and the localization of DAT on the plasma membrane is 
dictated by the various PTMs (German et al., 2015). A brief description of some of the important 
regulatory mechanisms is described below in Table 1. “DAT regulation mediated by signalling 
systems is complex, with some functions regulated by more than one pathway and some 
pathways regulating more than one function, indicating the presence of convergent and 
divergent mechanisms.” (Vaughan and Foster, 2013). 
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Figure 8: Schematic diagram of rat DAT (rDAT) showing the phosphorylation characteristics of DAT. 
PKC and MAPK domain phosphorylation sites in blue, with Ser7, Ser13, and Thr53 residues highlighted 
with large circles. Other intracellular Ser (S) and Thr (T) residues are shown in mauve, prolines flanking 
Thr53 that constitute an SH3 binding domain are shown in yellow (P), the CAMKII binding domain in the 
C-terminus is shown in green, and palmitoylation site Cys580 is shown in orange. Known and suspected 
kinase, phosphatase, and PIN1 inputs into Ser7, Ser13 and Thr53 are indicated with arrows, and dashed 
lines show indirect AMPH and PKC inputs into each site (Foster and Vaughan, 2017). 
 
2.6 Effect of Dopamine on Male Reproduction 
It is believed that the peripheral catecholaminergic system plays a role in the homeostasis of 
numerous organ functions (Peyrin and Dalmaz, 1975; Goldstein, 1997). In the periphery the 
major source of catecholamines is the sympathetic nervous system (Peyrin and Dalmaz, 
1975). As previously stated, dopamine found in peripheral tissues is released from neuronal 
cells or it may be synthesized within specific parenchyma of these tissues i.e., hepatocytes 
and the renal medulla via APUD cells (Rubí and Maechler, 2010). The adrenal glands are an 
alternative source of catecholamine production, as chromaffin cells are APUD cells because 
of their ability to store and synthesize neurotransmitters (Brainard and Mandell, 2009; Carbone 
et al., 2019). In the adrenal medulla, dopamine can be transformed into other catecholamines 
such as norepinephrine and epinephrine (Rondou, Haegeman and Van Craenenbroeck, 2010). 
The activity of sympathetic nerves predominantly controls the levels of dopamine found in the 
plasma. It may be released as the precursor molecule, L-DOPA, as well as norepinephrine into 
the parenchyma of target organs (Goldstein and Holmes, 2008; Rubí and Maechler, 2010). 
Exceptionally, in spite of the absence of specific dopamine sources in peripheral tissues, the 
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concentration of this catecholamine in the plasma is similar to that of epinephrine (Rubí and 
Maechler, 2010). It has been shown in humans and rats that the cells of the adrenal medulla 
and sympathetic nerves express the L-DOPA decarboxylase enzyme, which can synthesize 
dopamine from L-DOPA (Wahbe et al., 1982; Mappouras, Stiakakis and Fragoulis, 1990; Rubí 
and Maechler, 2010). During times of stress or exercise, the sympathetic nervous system and 
the adrenal glands are activated to release catecholamines such as norepinephrine and 
epinephrine for the classic fight or flight response (Mcgrady, 1984; Rubí and Maechler, 2010). 
In human plasma dopamine levels may also increase under conditions of stress and exercise, 
as it is recognized as a modulator of peripheral organ function (Otth et al., 2007).Blood plasma 
levels of circulating dopamine was found to be ~2.29 ng/mL in normal fertile males (Shukla et 
al., 2009). Autonomic innervation, (sympathetic and parasympathetic innervation) in the 
reproductive system is of great significance as it regulates a wide variety of functions, such as 
vascular dilation, smooth muscle contraction and the stimulation of prostatic or vaginal 
secretions (Andersson, Hedlund and Alm, 2000; Purves et al., 2001). Autonomic innervation 
has been well characterised in neurovascular and neuromuscular events, however the effects 
of autonomic innervation on reproductive capacity and fertility are not well established 
(Kempinas et al., 1998). 
The reproductive system is under the control of the hypothalamic-pituitary-gonadal (HPG) axis, 
however non-endocrine regulatory influences such as neurotransmitters, are likely to play a 
pivotal part via a “neuroendocrinotropic stimulatory complex” (Mayerhofer et al., 1996; Gnessi, 
Fabbri and Spera, 1997). During the course of the 1970s and 1980s, the interest in the function 
of catecholamines on male fertility piqued, as it was shown that they may have an effect on 
hamster sperm function (Adeoya-Osiguwa, Gibbons and Fraser, 2006). Experimentation to 
discover the causation of alterations in sperm functions in vitro; including, capacitation, motility, 
and acrosome reaction, lead researchers to identify catecholamines as a key modulator of 
these events. It has also been shown that both adrenal gland extracts, which include 
catecholamine precursors, as well as individual catecholamines, were found to stimulate 
events required for hamster sperm functions (Bavister, Yanagimachi and Teichman, 1976; 
Cornett and Meizel, 1978; Bavister, Chen and Fu, 1979; Meizel and Working, 1980). It is 
thought that the high levels of catecholamines found in the reproductive tracts of mammals 
arise from the abundant autonomic innervation of the gonads or from the adrenal glands via 
the bloodstream (Kempinas et al., 1998; Otth et al., 2007). An alternative source of these 
catecholamines was suggested to be the interstitial fluid within the testis, and the ovaries of 
human and non-human primates. Neuron-like cells expressing neuronal proteins and 
catecholamine-biosynthetic enzymes are present in these organs (Dees et al., 1995; 
Mayerhofer et al., 1996, Mayerhofer et al., 1998; Mayerhofer et al., 1999a; Mayerhofer et al., 
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1999b). It was demonstrated that human Leydig cells within the testes express four enzymes 
which are critical components involved in the biogenesis of catecholamines, namely, TH, 
AADC, dopamine beta-hydroxylase (DBH) and phenylethanolamine- N-methyltransferase 
(PNMT) (Romeo et al., 2004; Davidoff et al., 2005). TH is specifically the rate-limiting enzyme 
involved in the production of dopamine and norepinephrine, and thus it increases the 
probability that catecholamines may be synthesized from other sources, in addition to the 
innervation of reproductive organs by the sympathetic nerves (Urra et al., 2014). These 
intratesticular and ovarian sources of catecholamines, in concert with bloodstream sources 
could potentially modulate reproductive capacity and therefore play a role in fertility 
(Mayerhofer et al., 1998; Romeo et al., 2004). In 2001, Fait and colleagues conducted a study 
to determine the seminal concentrations of different catecholamines and their association with 
semen quality in human semen. They concluded that although the concentrations of 
norepinephrine and DOPA were much higher than that of the normal plasma values, they were 
not associated with semen quality (Fait et al., 2001). High concentrations of catecholamines 
were detected in the oviduct luminal fluid of humans, pigs, rabbits, and cows. Catecholamine 
concentrations varied in the different regions of the oviduct and they were differentially 
expressed during the different stages of the oestrous cycle. It was thus suggested that 
catecholamines may modulate tubal motility (Helm et al., 1982; Chaud et al., 1983; 
Khatchadourian et al., 1987; Kotwica et al., 2003). 
Considering the sizeable effects that catecholamines seemed to play in male fertility, it was a 
natural step to begin searching for the presence of receptors for these catecholamines in the 
reproductive system. Previously it was thought certain plasma membrane receptors were 
neuron-specific and only found in the brain, however, these “neural” receptors were detected 
in other somatic cells. The mammalian spermatozoa appear to possess many of these 
neuronal receptors, and they play a role in sperm function (Meizel, 2004). In 1990, Young and 
Laing suggested that rabbit spermatozoa must possess catecholaminergic binding sites after 
they tested the effect of the antipsychotic drug, Spiperone, on sperm. It bound to the both the 
heads and tails of the spermatozoa (Young and Laing, 1990). Nevertheless, the first concrete 
evidence suggesting a catecholaminergic presence in the reproductive system came in 2006 
with the identification of functional α- and β-adrenergic receptors in mammalian spermatozoa 
(Adeoya-Osiguwa, Gibbons and Fraser, 2006). This discovery was not surprising as 
catecholamines were detected in large quantities within the reproductive tracts of mammals 
(Khatchadourian et al., 1987; Fait et al., 2001) however, the resultant impact of this discovery 
was controversial as it meant that the use of amphetamine-related compounds (ecstasy, 
Ritalin, Benzedrine) could possibly have a positive impact on fertility in vivo, especially on 
females (Adeoya-Osiguwa, Gibbons and Fraser, 2006).  
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In 2007 the novel identification of a peripheral dopaminergic receptor, D2, in rat male germ 
cells lead to new and unexpected roles for dopamine signalling in the male reproductive tract 
(Otth et al., 2007). Rat germ cells including spermatids and, mature spermatozoa and testes 
were found to express both the D2L and the D2S receptors, which were located via 
immunofluorescence as well as immunoblotting (Otth et al., 2007). Spermatozoa from  mouse, 
bull, and humans were also shown to express these proteins (Ramírez et al., 2009). Analysis 
with a polyclonal antibody detected two bands with an apparent molecular weight of 47-50kDa 
for sperm and higher molecular weight bands in the brain and testis (Otth et al., 2007; Ramírez 
et al., 2009). This observed heterogeneity could be explained by homodimerization or hetero 
oligomerization of the D2 receptor (Canals et al., 2003; Guo, Shi and Javitch, 2003; Lee et al., 
2003; Kearn et al., 2005; Otth et al., 2007). A functional D2 receptor (DRD2) was found to be 
present in boar sperm. It was positively identified and localized to the acrosomal region of boar 
sperm after 2 hours of incubation in capacitation media. This study proved that the dopamine 
receptor D2 is highly conserved across mammalian species and that localization is dynamic 
as it depends on the capacitation status of the sperm (Ramírez et al., 2009).  
Capacitation is required for spermatozoa to be able to fertilize the oocyte. It is defined by a 
series of changes that the sperm undertake during their transit through the female reproductive 
tract (Chang, 1984; Yanagimachi, 1994; Leahy and Gadella, 2011; Wertheimer et al., 2013). 
The main aim of capacitation is to ensure that the sperm reach the oocyte at the appropriate 
time and in the proper state to begin fertilization (Chang, 1984; Yanagimachi, 1994). The finely 
tuned complex procedure involves the loss of seminal fluid, alterations in the sperm membrane 
fluidity caused by ion fluxes and biochemical modifications, the development of hyperactive 
motility and the initiation of signal transduction pathways (Yanagimachi, 1994; Schuh et al., 
2006; Schuh, Hille and Babcock, 2007; Wertheimer et al., 2013). All these steps prepare the 
spermatozoa for the induction of the acrosome reaction which is required for the spermatozoa 
to bind to the zona pellucida and ultimately fertilize the oocyte (Chang, 1984; De Lamirande, 
Leclerc and Gagnon, 1997; Visconti and Kopf, 1998; Guraya, 2000). Capacitation in vitro can 
be achieved by simply washing the spermatozoa and removing the seminal fluid, as a first step 
(Leahy and Gadella, 2011). Capacitation may also be induced, in vitro, by adding media 
designed to mimic the electrolytic composition of the female oviduct, this media consists of 
energy substrates such as glucose, pyruvate, and lactate (Hoppe, 1976). Bicarbonate (HCO3-
) is also an important component of the capacitating media as the influx of HCO3- into sperm 
induces soluble AC (sAC) to increase cAMP levels, thereby activating PKA to phosphorylate 
certain proteins in control of flagellar movement (P.E. Visconti et al., 1995; Breitbart, 2002; 
Wennemuth et al., 2003; Wertheimer et al., 2013; Soriano-Úbeda et al., 2019). In addition 
changes in sperm swimming trajectories have been observed during capacitation, these 
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changes have been defined as hyperactive motility (Aitken et al., 1985; Morales, Overstreet 
and Katz, 1988; Kay and Robertson, 1998). Bovine Serum Albumin (BSA) is also added to 
capacitating media and induces Ca2+ influx into sperm, although the mechanism underlying 
the influx is not well understood (Xia and Ren, 2009). The Ca2+ influx is required for the 
increase in motility during capacitation and the destabilization of the membrane which prepares 
sperm for ultimately undergoing the acrosome reaction (Chang, 1984; Breitbart, 2002; Carlson, 
Hille and Babcock, 2007; Xia and Ren, 2009). 
Protein function is controlled by many factors - phosphorylation and dephosphorylation are 
mechanisms utilized to alter protein expression and functionality (Hunter, 2000). Although 
serine and threonine residues may get phosphorylated, tyrosine phosphorylation may be the 
exclusive indicator of a signal transduction pathway in a cell (Naz and Rajesh, 2004; Sepideh 
et al., 2009). Tyrosine phosphorylated proteins within spermatozoa play an important role in 
sperm functioning. They have been proposed to initiate and regulate sperm motility, sperm 
capacitation and the acrosome reaction (Visconti et al., 1995a; Visconti et al., 1995b). Tyrosine 
phosphorylation seems to be regulated by cAMP and PKA (Visconti et al., 1995a; Visconti et 
al., 1995b; Bajpai and Doncel, 2003). As cAMP is synthesized by AC it is interesting to note 
that sAC, found in mammalian sperm, is insensitive to metabotropic receptors in contrast to 
transmembrane AC (tmAC), instead sAC is said to be regulated by HCO3- and Ca2+ ions 
(Jaiswal and Conti, 2003; Litvin et al., 2003; Wertheimer et al., 2013). Subject to controversy, 
however, is the existence of tmAC in sperm, where some studies have proved their existence 
and others have failed to identify them (Monks, Stein and Fraser, 1986; Livera et al., 2005; 
Strünker et al., 2011; Brenker et al., 2012). Wertheimer et al., has demonstrated that tmAC are 
present on mouse spermatozoa and play important roles in the regulation of sperm functions 
(Wertheimer et al., 2013). The first event of capacitation is illustrated by the elevation of 
intracellular Ca2+and HCO3 which activate AC, thus producing more cAMP. The cAMP 
activates PKA which has been shown to be involved in the phosphorylation of multiple sperm 
proteins during capacitation, thereby leading to hyperactivation and eventually AR (Breitbart, 
2002; Schuh et al., 2006; Carlson, Hille and Babcock, 2007; Schuh, Hille and Babcock, 2007). 
Low (100 nM) concentrations of dopamine have been shown to affect capacitation, specifically 
tyrosine phosphorylation. This was suggested to be through D2DR activation; however, high 
(1 mM) concentrations of dopamine significantly decreased the tyrosine phosphorylation 
pattern and sperm motility (Ramírez et al., 2009). It was postulated that the inhibitory effects 
of dopamine on tyrosine phosphorylation and motility may be mediated by an excess of 
dopamine oxidation products as these are known to be toxic both in vitro and in vivo (Berman 
and Hastings, 2001; Ramírez et al., 2009). 
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Catecholamines such as dopamine and norepinephrine were shown to exhibit a biphasic effect 
at different concentrations in sperm. Literature on seminal plasma levels of dopamine is 
scarce, however Shukla et al., found via reverse-phase high pressure liquid chromatography, 
that ~4.34 ng/mL is found in the seminal plasma of normal fertile men (Shukla et al., 2009). 
Low (100 nM) concentrations of dopamine treatments were shown to be protective, by 
increasing the sperm viability, whereas high concentrations (1 mM) negatively affected sperm 
parameters such as motility and acrosomal integrity (Way and Killian, 2002; Ramírez et al., 
2009). Numerous studies have evaluated the effect of known DAT inhibitors, such as cocaine 
and amphetamines, on spermatozoa or testis and hypothesized that since these molecules 
elicit some effect on sperm and testes, a mechanism for  transport must exist (Yazigi, Odem 
and Polakoski, 1991; Yelian et al., 1994; George et al., 1996; Li et al., 1997, 1999).  Taken 
together these findings suggest that catecholamine transporters are present in sperm. 
Ramírez et al., investigated the presence of DAT on spermatozoa of mammalian species such 
as human, mouse, bull, and horse, however, they only reported on the identification thereof in 
boar sperm (a supplementary IF micrograph alludes to the presence of DAT on the other 
mammalian species mentioned above). These same authors document the presence of DAT 
in boar sperm, on WB membranes with an approximate molecular weight of 75-80 kDa 
(Ramírez et al., 2009). This was the first evidence pointing to mammalian sperm possessing a 
catecholaminergic phenotype and therefore could possibly be sensitive targets for addictive 
drugs and antipsychotics such as cocaine and amphetamine (Ramírez et al., 2009). 
Monoamine Transporters DAT, NET and SERT were identified in equine spermatozoa. 
Immunofluorescence assays depicted- NET distribution within sperm seems to be localized to 
the acrosomal region. A similar pattern was observed for SERT, however a weak signal 
detected in the mid-piece and the tail was also present for SERT (Urra et al., 2014). The 
presence of these monoamine transporters was further established using Western Blotting 
techniques; NET migrated to a band of ~70kDa and SERT to ~58kDa (Urra et al., 2014). Most 
importantly a functional DAT was localized via indirect immunofluorescence on stallion 
spermatozoa, with a strong immunoreaction at the acrosomal region and weaker 
immunoreactivity in the principal piece of the sperm tail (Urra et al., 2014). The presence of 
this protein was further proved by western blotting experiments. Rat brain extracts were used 
as positive controls. Analysis with a specific anti-DAT antibody revealed a band at ~70kDa for 
the equine sperm and several bands ranging between 45-120kDa for the positive control, 
which is due to the degree of glycosylation and the formation of homo-oligomers (Urra et al., 
2014). Urra and colleagues focus was on the identification of DAT in equine spermatozoa, but 
similarly to Ramírez et al., 2009, they also investigated the presence of DAT in boar, human 
and bull sperm with WB analysis techniques (supplementary data of WB membrane suggest 
Stellenbosch University  https://scholar.sun.ac.za
29 
 
DAT appears at ~70 kDa for all the species mentioned above) (Urra et al., 2014). A functionality 
assay using fluorochrome 4-[4-(Dimethylamino)styryl]-N-methylpyridinium iodide (ASP+) as a 
substrate demonstrated that DAT is functional in equine sperm. The transport activity (Km) of 
the DAT found in equine sperm was shown to be 3 times that of DAT in HEK293 (cultured 
human embryonic kidney cells, commonly used in cell culture experiments) cells. The higher 
Km could suggest that equine DAT has a lower affinity for dopamine and could require higher 
levels of substrate to operate. It would seem that equine DAT is insensitive to low doses of 
dopamine, but adversely higher doses would impact negatively on sperm functions, as 
previously mentioned. The negative effects of high doses of dopamine were partially reversed 
by incubating equine sperm with the highly selective DAT inhibitor, Vanoxerine (GRB12909). 
High (1 mM) concentrations of dopamine were shown to significantly decrease total motility 
after 1 hour of incubation, however upon the addition of Vanoxerine, this effect was partially 
reversed (Urra et al., 2014). 
In summary all the evidence taken together suggests dopamine’s modulatory role on sperm 
physiology is complex. Sperm functions are regulated by signals present in the male and 
female reproductive tracts. Sperm functions associated with neural signals have predominantly 
been studied in a unidimensional approach, where one ligand activates one receptor or 
transporter thus altering sperm functions. However, sperm functioning invivo is completely 
different as they are exposed to multidimensional signalling complexes (Ramírez-Reveco et 
al., 2017). 
Therefore, the study aims to answer the problem statement- are DATs present on human 
sperm membranes and what are the effects of different concentrations of dopamine on human 
sperm parameters? By utilising WB and IF techniques, the study aims to locate DAT and 
thereafter determine the effects of different concentrations of dopamine on human sperm 
parameters. 




Materials and Methods 
3.1 Introduction 
This chapter  provided an overview of the materials used in the study as well as where they 
were obtained from. It  also details all the methods employed for each experiment. The study 
comprises of rat tissue collection for use as positive controls and human semen collection, to 
identify DAT and analyse the effects of dopamine on human sperm functions. 
 
3.2 Ethical Clearance 
Participants from the Faculty of Medicine and Health Sciences (FMHS) were recruited via a 
flyer and voluntarily agreed to participate in the study as sperm donors. Institutional Permission 
was obtained from Stellenbosch University (service desk ID: IRPSD-1982) (see Appendix A). 
All participants were informed of the full research protocol and signed an informed consent 
form (ICF), wherein it was made clear that they would be guaranteed anonymity and the 
samples would solely be used for research purposes as stated in the ICF. Participants were 
assigned a unique donor code and referred to by it throughout the entire study. Ethical 
clearance for use of the human semen samples in this study was granted by the Health 
Research Ethics Committee (HREC) of Stellenbosch University. Ethics Reference number: 
S/20/08/200 (see Appendix A). 
The use of the animal tissue was approved by the Research Ethics Committee: Animal Care 
and Use. The animals collected for this study form part of a larger study titled: The vascular 
and endothelial effects of HIV & antiretroviral therapy – functional effects and mechanisms, 
with Ethics Reference number ACU-2019-8939. An amendment to the original ethics 
application was granted and 20 animals were collected as part of the current study. Ethics 
Reference number ACU-2019-10563 (see Appendix A). 
3.3 Study Setting 
The study was performed at the Stellenbosch University Reproductive Research Group 
(SURRG) laboratory in the Division of Medical Physiology, FMHS, Stellenbosch University, 
Tygerberg. 
3.4  Study Design 
The study was designed to be accomplished by firstly collecting rat tissue to serve as control 
and thereafter collecting human semen samples for experimentation. The animal tissue was 
collected and stored away for further analysis. Figure 9 provides a brief description of how the 
rat tissue was collected. A total of 20 rats were utilized for the current study and rat brain tissue 
was collected and used as positive controls. For the human semen collection, a total of 58 
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human semen samples were collected (n=58). Twenty-four samples were collected and frozen 
away for Western Blot (WB) analysis; a further 10 samples were collected and analysed with 
Immunofluorescence (IF) and 24 samples were collected and used for the dopamine treatment 
experiments. A brief study design of the experimental procedure followed can be seen in figure 
10. 
 
Figure 9: Brief description of animal tissue collection. (DAT- Dopamine Transporter, WB- Western 
Blot)




Figure 10: Brief description of the experimental design. (DAT- Dopamine Transporter, IF- 
Immunofluorescence, WB- Western Blot) 
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3.4.1 Animal tissue collection 
All animals  were raised under the same conditions and following 16 weeks of being kept on a 
control diet they were sacrificed. Before sacrifice, the animals were weighed, and the end body 
weights recorded. Twenty control male Wistar rats were sacrificed by means of a sodium 
pentobarbitone injection and exsanguination.  
After exsanguination, the animals were decapitated, the skull was cracked open and the whole 
brain was removed. The brain was subsequently bisected and kept on ice in a petri dish. 
Thereafter the brain halves were immediately snap frozen in liquid nitrogen in foil envelopes 
and stored at -80°C until further analysis.   
 
3.4.2 Human semen collection 
Semen samples were collected from volunteer donors from the FMHS. The participants 
recruited were healthy donors aged between 18 and 25 years. Exclusion criteria included: 
• heavy smokers (3-10 cigarettes a day) 
• frequent alcohol consumption (˃2 units per day) 
• recreational drug users (e.g., marijuana; LSD and ecstasy) 
• psychostimulant drug use of any kind (e.g., Ritalin, Concerta and Adderall). 
All donors were required to abstain from any sexual activity for 2-7 days and samples were 
collected according to the guidelines outlined by the World Health Organization (WHO, 2010). 
Semen was collected via masturbation into a wide-mouthed sterile plastic container, provided 
by the Stellenbosch University Reproductive Research Group (SURRG). The samples were 
immediately placed in an incubator (Heal Force®) set at 37°C, with 5% CO2 and 95% humidity. 
All samples were allowed to liquefy for 30 minutes prior to any analysis. Semen was used for 
the spermiogram and analyses to be completed on day of collection. Sperm samples were also 
centrifuged (Hermle Z 326 K, Lasec, South Africa), the pellets were collected and snap frozen 
in liquid nitrogen before being stored away at -80°C until further analysis. 
 
3.5 Materials 
Dopamine Hydrochloride (5g) obtained from Sigma-Aldrich, South Africa. Dulbecco’ Modified 
Eagles Medium (DMEM), Phosphate Buffered Saline (PBS), Foetal Bovine Serum (FBS), 
Bovine Serum Albumin (BSA), Triton x-100, Fluorescein-Isothiocyanate Pisum Sativum 
Agglutinin (FITC-PSA), DPX Mountant and Dako Fluorescent Mounting medium were obtained 
from Sigma-Aldrich (South Africa). Eosin and Nigrosin were obtained from Fertipro (NV, 
Belgium). Anti-Dopamine Transporter antibody [ab111468] and Donkey Anti-Rabbit IgG H&L 
(Alexa Fluor® 488) [ab150073] secondary antibody was obtained from Abcam (Biocom, South 
Africa). Hoechst 33342, nuclear stain, was obtained from Thermo Fisher Scientific (South 
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Africa). Anti-Rabbit IgG HRP-linked secondary antibody was obtained from Cell Signalling 
technology (South Africa). 
 
3.6 Standard Semen Analysis (Spermiogram) 
The standard semen analysis, also known as the spermiogram, is used to test the semen 
quality and basic sperm parameters. The spermiogram provides a baseline of information 
before any treatments to the sperm samples and is also referred to as the neat analysis. The 
basic semen analysis was assessed in terms of the guidelines defined by the WHO (WHO, 
2010). The basic semen analysis consisted of macroscopic and microscopic evaluations. The 
macroscopic evaluation included measuring the volume, pH, and viscosity of the semen 
sample, while also noting the colour of the sample. The microscopic evaluation included 




The volume of an ejaculate is most commonly the first parameter assessed during the basic 
semen analysis. It is important to quantify the volume of the entire ejaculate and get a precise 
measurement as this is indicative of all the cellular and non-cellular elements contained within 
the sample. The WHO sets a lower reference limit of 1.5 mL (5th centile, 95% confidence 
interval (CI) 1.4-1.7 mL) for semen samples to be regarded as normal (WHO, 2010). Once 
liquefied, semen samples were transferred with a Pasteur pipette directly from the sample 
container into a graduated 15 mL falcon tube, and the volume was measured on the balance 
scale (Kern, Sigma-Aldrich, South Africa) and recorded in millilitres as per WHO guidelines. 
Samples with a volume lower than the reference limit was excluded from the study. All collected 
samples passed the lower reference limit and were included in the study. 
 
3.6.2 pH 
The pH of an ejaculate is an important parameter to measure as it gives a reflection of the 
various accessory gland secretions (AGS). According to the WHO a normal pH falls within a 
range of 7.2-7.8 (WHO, 2010). Values outside of the normal pH range could be indicative of 
sperm alterations or infections. The pH was measured after liquefaction by means of litmus pH 
strips and a colour wheel (pH- indicator paper, Merck Millipore). A 2μL drop was pipetted onto 
a small strip of litmus paper and the resultant colour change compared to the colour wheel. 
Samples with pH measurements outside the normal range were excluded from the study. All 
samples collected fell within the normal pH range and none were excluded. 
 




Viscosity measures the seminal fluids resistance to natural flow. It is important to measure 
viscosity as a high degree of viscosity could interfere with sperm motility and concentration 
determination. The viscosity of the semen sample was measured by the duration of time it took 
the sample to fill up a chamber slide. Leja® 8 Chamber slides (2153 GN Nieuw Vennep, The 
Netherlands) with a 20-micron depth chamber were used to assess the viscosity. Two 
microlitres was pipetted into the chamber and the time it took to fill up was measured. The 
sample was deemed too viscous if it took ˃10 seconds to fill the entire chamber. If the sample 
was too viscous it was diluted in a 1:1 ratio with DMEM. 
 
3.6.4 Colour 
Semen normally displays a white to opaque colour. It is important to note the colour as varying 
from the norm could indicate an infection. Brownish or red colour indicates that there is blood 
in the semen, this is known as haemospermia. Semen appearing yellow or green is likely due 
to medication, however brown semen is indicative of infections including sexually transmitted 
infections (STI’s) such as, gonorrhoea or chlamydia. The colour of the semen was determined 
visually and classified either normal or abnormal. Only those classified as normal were 
included in the study, all samples collected were classified as normal and included in the study. 
 
 
3.6.5 CASA-related analysis 
The CASA system comprises of a computer with the appropriate software, and a microscope 
with a camera attached. The Sperm Class Analyser®(SCA®) software system, version 
6.3.0.59 (Microptic, S. L., Barcelona, Spain) is an automated software system used to track 
and analyse spermatozoa and take images thereof. The CASA system is comprised of a Nikon 
Eclipse 50i Microscope (IMP, Cape Town, South Africa), a temperature regulated microscope 
stage and Basler A312fc digital colour camera (Microptic, S. L., Barcelona, Spain). The 
microscope was set to phase-contrast (Ph1); brightness, 100; 10x objective; the green filter 
and the temperature of the stage set to 37°C. 
3.6.5.1 Motility 
The most significant parameter assessed during a basic semen analysis is the sperm motility. 
Spermatozoa require the ability of motility to be able to travel along the female reproductive 
tract to reach the oocyte. Sperm motility is measured as the percentage of moving 
spermatozoa in a semen sample. The WHO classifies a total motility of 40% (38-42%) and 
progressive motility of 32% (31-34%) as normal (WHO, 2010).Sperm motility is assessed by 
means of the CASA aided by the SCA® automated software system. The SCA® system 
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analyses a wide range of parameters including total motility, progressive motility, and various 
kinematics of the sperm head. The “Human50” setting was selected on the SCA® software, 
which is optimized for human sperm. A 2μL drop of semen is pipetted into a 20 μm Leja® 
chamber slide and observed under the microscope. A minimum of 5 randomly selected fields 
on the slide were recorded and 50 images per second captured. At least 1000 spermatozoa 
were examined.  
3.6.5.2 Concentration 
Sperm concentration is an essential parameter in determining fertility and it is routinely 
measured during a basic semen analysis.  Sperm concentration is the number of spermatozoa 
per millilitre in a semen sample. Total sperm count represents the concentration of 
spermatozoa per ejaculate. WHO sets a lower limit of 15 million spermatozoa per millilitre 
(M/mL) (12-16 M/mL) and 39 million spermatozoa per ejaculate (33-46 M/mL) (WHO, 2010). 
Men with a total sperm count <39 M/mL are considered oligozoospermic. The concentration of 
a sample is measured in conjunction with the motility using the CASA and a 20μm Leja® 
chamber slide.  
3.7 Sample preparation 
Once the sample has liquified, undergone the basic semen analysis and adhered to the 
guidelines prescribed by WHO including- a volume of ≥1.5 mL, a concentration of ≥15 x 106 
spermatozoa per mL, a total motility of 40% and a progressive motility of 32%, it has passed 
the neat analysis. A single wash was employed to remove the seminal plasma and all the 
cellular debris. The single wash includes adding an equal volume of DMEM, to the semen 
sample in a 1:1 ratio. The sample was then centrifuged at 1500 rpm for 15 minutes at room 
temperature (RT) (22°C). The supernatant was discarded using a Pasteur pipette and the 
pellet was resuspended in 2-3 mL of DMEM. The pellet is disturbed and dissolved in the 
DMEM. The washed sample was measured for motility and concentration once again. The 
sample was used for further experimentation if it had a concentration of ≥15 x 106 spermatozoa 
per mL. 
 
3.8 Immunofluorescence (IF) 
For immunodetection by fluorescence, an indirect immunofluorescence analysis was utilized. 
Indirect Immunofluorescence, also known as secondary immunofluorescence, is a technique 
employed to detect targets of interest using two antibodies. The primary antibody binds to the 
target of interest and the secondary antibody, which carries the fluorophore, recognizes, and 
binds to it (Wardyn and Jeyasekharan, 2018). For the detection of DAT, an Anti-Dopamine 
Transporter antibody was utilized as the primary antibody and a donkey Anti-Rabbit IgG H&L 
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(conjugated to Alexa Fluor® 488) as the secondary antibody. Hoechst 33342 was employed 
as a counterstain for the nucleus. 
 
For the indirect immunofluorescence analysis, we utilized a modified protocol initially described 
by Ramírez et al., (2009). The samples are prepared as described in section 3.7. The sperm 
samples were diluted in 5 mL round bottom Falcon tubes (Corning, USA) with 1% BSA-PBS 
(wash buffer- see Appendix B) to attain the appropriate number of spermatozoa, 20 M/mL, and 
then centrifuged (Hermle Z 326 K, Lasec, South Africa) for 10 minutes at 500 x g force (relative 
centrifugal force- rcf). The supernatant was decanted, and the spermatozoa were fixed by 
resuspending in 100 μL of 2% paraformaldehyde and incubating at RT for 15 minutes, 
whereafter they were washed twice. The wash step includes topping up to 1 mL with wash 
buffer and centrifuging for 10 minutes at 500 x g. The sperm were then permeabilized in 100μL 
of 0,3% Triton X-100 in 5% BSA-PBS (see Appendix B) at RT for 10 minutes, whereafter they 
were washed twice. The spermatozoa were blocked for non-specific binding in 500μL 10% 
FBS at RT for 40 minutes, after which, the sperm were washed twice- the tubes were left to 
stand for 5 minutes on the bench top and thereafter centrifuged for 10 minutes.  
 
For staining, the spermatozoa were incubated overnight in the fridge at 4°C with 10μL of Anti-
Dopamine Transporter antibody (Anti-DAT) to a final concentration of 5μg/mL. After incubation 
with the primary antibody, the sperm were washed twice, 5 minutes on the benchtop and 10 
minutes in the centrifuge to remove the unbound primary antibody. The secondary antibody, 
Donkey Anti-Rabbit conjugated to Alexa Fluor® 488, was prepared in a 1:1000 dilution and 
100μL of secondary antibody and 1μL of 1μg/mL Hoechst, was added to the appropriate tubes 
and allowed to incubate for 40 minutes in a humidified chamber. Hoechst is a nuclear stain 
that is highly cell membrane permeant and is routinely used as a nuclear counterstain as it is 
less toxic than other dyes, which ensures a higher viability of stained cells (BD Biosciences-
Europe, 2009). The sperm were then washed twice, 5 minutes on the benchtop and 10 minutes 
in the centrifuge to remove the unbound secondary antibody. Finally, the sperm were 
resuspended in 100μL 1%BSA-PBS buffer and mixed well. A 10μL drop was added to a 
Superfrost Plus positively charged slide (Adkin Med-Lab Supplies, South Africa) and a smear 
was made. The smear was allowed to air dry for 1-4 hours, whereafter it was mounted with 
Dako fluorescent mounting medium.  
 
Confocal microscopy was performed for the analysis of the samples using the Carl Zeiss 
LSM780 with ELYRA PS1 Super-resolution platform (Carl Zeiss, Germany). An Alpha Plan-
Apochromat 100x/1.46 Oil DIC M27 Elyra objective, along with the 405 nm laser (for the 
detection of Hoechst 33342), 488 nm laser (for the detection of DAT-Alexa Fluor® 488) and 
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the GaAsP detector 32+2 PMT and the Transmitted light detector T-PMT was utilized for 
imaging. Alexa Fluor® 488 was detected in the range 499-543 nm and nuclear stain Hoechst, 
was detected in the range 415-460 nm. For data collection, Z-stacks were acquired with a 
variable step width for each image. Maximum intensity projections of Z-stacks were processed 
and generated in the Zeiss Zen Blue 2012 software (Carl Zeiss, Germany) and utilized for 
subsequent analysis. 
Figure 11 depicts the controls used for the experimental setup; the negative controls were 
obtained when sperm were incubated with only secondary antibody. 
Figure 11: Schematic of the experimental setup for immunofluorescence assay. Tube 1 represents the 
positive control, containing the primary and secondary antibodies as well as the nuclear stain. Tube 2 
represents another positive control without the nuclear stain and tube 3 represents the negative control, 
containing only the secondary antibody. 
 
3.9 Western Blotting Analyses (WB) 
Western Blotting is an analysis technique for the detection of immobilized specific proteins 
(antigens), conjugated with HorseRadish Peroxidase (HRP) antibodies. The procedure 
involves the electrophoretic transfer of proteins from Sodium Dodecyl Sulphate (SDS)- 
polyacrylamide gels to a Polyvinylidene Fluoride (PVDF) transfer membrane. Polyacrylamide 
gel electrophoresis (PAGE) is utilized to separate denatured proteins based on their size 
(molecular weight). Visualization on a membrane after the transfer provides further detail on 
protein expression. Western Blotting is a useful analysis tool that not only confers information 
about protein size (in comparison to a size marker in kDa) but also protein expression (in 
comparison to a control sample or tissue). Western blot analysis is a time-consuming 
experimental procedure that may take up to 3 days to complete. On day 1 the lysates are 
prepared, and the protein concentration is determined by the Bradford Protein Assay. On day 
2 the gels are made, transferred to membranes, and incubated with primary antibody 
overnight. Finally, on day 3 the membranes are incubated with secondary antibody and 
visualized by chemiluminescence. For the detection of the protein of interest, DAT, an Anti-
Dopamine Transporter antibody was used as the primary antibody and an Anti-Rabbit IgG 
HRP-linked antibody was used as the secondary antibody. Rat brain tissue was used as the 










1 2 3 
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3.9.1 Protein extraction- Brain Tissue 
The rat brains were collected as described in section 3.4.1 and were used as the positive 
control for the detection of DAT protein. Whole brains were removed from -80°C storage and 
pulverised. The pulverization step was done using a mortar and pestle, pre-cooled in liquid 
nitrogen. Approximately 0.5-0.6g of tissue was weighed (Mettler Toledo, Switzerland) out after 
pulverization. Only two samples were utilized for the final WB analysis.. Brain tissue from 
control rats 1 and 2 were labelled C1 and C2 respectively. 
C1= 0.53g 
C2= 0.52g 
3.9.2 Protein extraction- Sperm 
Twenty-four human sperm samples were collected for Western Blot analysis and used for the 
detection of DAT protein. Five donors donated samples to reach n=24. Semen was collected 
and prepared as described in section 3.7 and stored at -80°C. On the day of the lysate 
preparation the samples were taken out of the freezer and incubated at 37°C for 30 minutes 
to thaw. Twelve samples were pooled and represent one sample, therefore from 24 donors 
two samples were generated, namely S1 and S2. The samples were centrifuged at 1500 rpm 
for 10 minutes and the pellets were collected.  
S1 (485.70 M/mL) = Donor 1 (6 sperm samples) + Donor 2 (6 sperm samples)  
S2 (724,37 M/mL) = Donor 3 (7 sperm samples) + Donor 4 (3 sperm samples) + Donor 5 (2 
sperm samples) 
3.9.3 Lysate preparation and Bradford Protein Assay 
To prepare the lysates the pulverized tissue and the sperm pellets were first homogenized to 
break apart the cells. On ice, 700 μL of Lysis Buffer (LB), prepared as described in Table 2, 
was added to labelled Eppendorf’s, containing 7 stainless steel beads (1.6 mm) (Next 
Advance, Inc, USA). The samples were homogenized using the Bullet Blender at 4°C, set at 
speed eight for one-minute, this was repeated three times with five-minute intervals in 
between. The samples were then centrifuged (BKC-TH16R High Speed Refrigerated 
centrifuge, Axiology Labs, South Africa) for 20 minutes at 15000 rpm at 4°C. The supernatant 
was collected and transferred to new labelled Eppendorf’s.  
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    Amount of 
10X stock 
for 10 mL 
Action 
20 mM Tris-HCl [pH 7.5] 
 





10 mM Chelating agent 
   1 mM EDTA [ethylene diamine 
tetra-acetic acid] 




150 mM NaCl [Sodium Chloride] 1 M 1,5 mL Salt 





    2,5 mM tetra-Na-Pyrophosphate  0.01 g 
Serine/Threonine 
Phosphatase Inhibitor 
 1 mM Na3VO4 (0,18 g/10 mL H2O) 
[Sodium Orthovanadate] 
10 mM 1 mL 
    Tyrosine and Alkaline 
Phosphatase Inhibitor 
    SDS [Sodium Dodecyl Sulphate] 1% 1 mL Detergent 
50 μg/mL PMSF [Phenyl 
Methyl Sulfonyl Fluoride] 
100 mM 30 μL    Serine protease inhibitor 
    PI [Protease Inhibitor] cocktail: 








• Leupeptin hemisulfate salt 
• Pepstain A 
 
 50 μL 
• Serine protease 
inhibitor 




• Cysteine protease 
inhibitor 
• Serine and 
Cysteine protease 
inhibitor 
• Acid protease 
inhibitor 
1% Triton X-100 10% 1 mL Detergent 
Fill up to 10 mL with distilled water 
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The Bradford Protein Assay is used to determine the concentration of protein in a sample 
compared to a BSA standard, using a spectrophotometer. The BSA standards were used to 
generate a standard curve, using the optical density (OD) readings and the protein 
concentration of the standards (known)  see Appendix C. The Bradford reagent was prepared 
in a 1 in 5 dilution, 20 mL of Bradford reagent was added to 80 mL of dH2O and filtered. Figure 
12 depicts how the samples and standards were prepared - BSA was used to prepare Bradford 
standards in duplicate (C); a 10x dilution was made with the supernatant (A), whereafter a 20x 
dilution was made in duplicate and thoroughly vortexed (B); Filtered Bradford reagent (900 μL) 
was added to the BSA standards (C) and the duplicate samples (B). Using a 
spectrophotometer, the OD were recorded. From the standard curve (generated from the BSA 
standards), (see Appendix C), a line of best fit was plotted, and an equation generated. The 
equation and the OD readings of the samples (B) was used to determine the protein 
concentration in each sample. . 
The lysate  contained the sample, the sample buffer (SB) and the lysis buffer. SB accounts for 
a third of the volume of the lysate and therefore a calculation determined the amount of sample 
and LB to be added. SB was prepared by adding 850 μL Laemmli Buffer (Table 3) to 150 μL 
β-mercaptoethanol. 
 
Figure 12: Bradford Protein Assay- setup 
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Bromophenol Blue 0.004% 
Tris-HCl 0.125 M 
 
The lysates were prepared accordingly, containing the SB, LB, and sample (supernatant) 
ensuring a final protein concentration of 27.5 μg per 12 μL of lysate (refer to Appendix C).. 
Lysates were frozen away at -80°C until further analysis. 
3.9.4 Separation and Transfer of Proteins 
The proteins were now ready to be separated by gel electrophoresis. The Bio-Rad Mini Gel 
Protean System (Bio-Rad, CA, USA) was assembled with a 1 mm thick spacer glass plate. A 
10% stain-free running gel was prepared as described in Table 4. Since the protein of interest 
has a molecular weight of 60-80 kDa, a 10% gel is optimal to separate proteins. Immediately 
after pouring the running gel into the cast, a few drops of butanol was added to prevent 
oxidation of the gel, remove bubbles and to ensure a straight-line formed. The gel was allowed 
to set for 30 minutes whereafter the butanol was washed off with dH2O. A 4% stacking gel was 
prepared as described in Table 5. Once the stacking gel was poured onto the running gel, the 
combs were inserted, they formed the wells. The stacking gel was allowed to set for 15 minutes 
whereafter the combs were removed. 
Table 4: Running Gel- stain free 
Reagent Stock 10% 
dH2O  4,85 mL 
Stain Free  50 μL 
    Tris-HCl (pH 8.8) 1,5 M 2,5 mL 
SDS 10% 100 μL 
Acrylamide 40% 2,5 mL 
*APS 10% 50 μL 
*TEMED 99% 20 μL 
* APS and TEMED react fast to set the gel, add last  
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Table 5: Stacking Gel 
Reagent Stock 10% 
dH2O  3,05 mL 
   Tris-HCl (pH 6.8) 0,5 M 1,25 mL 
SDS 10% 50 μL 
Acrylamide 40% 500 μL 
*APS 10% 50 μL 
*TEMED 99% 10 μL 
* APS and TEMED react fast to set the gel, add last 
 
The lysates were removed from the -80°C storage and thawed on ice. The samples were boiled 
for 5 minutes and centrifuged for ~30 seconds to remove condensation. The gels were placed 
into the electrophoresis tank and topped up with running buffer (see Appendix B). A Hamilton 
pipette was used to load the samples and the molecular weight marker (ladder), into the wells 
of the gel. The samples to be loaded are the brain samples C1 and C2, which serve as the 
positive controls, and the two sperm samples S1 and S2. Two gels were prepared and loaded 
as described in figures 13 and 14. 
 
Figure 13: Gel 1, stain-free 
 
Figure 14: Gel 2, stain-free 
  
• Lane 1- 5 μL 
• Lane 2- 12 μL 
• Lane 3- 12 μL 
• Lane 5- 12 μL 
• Lane 6- 12 μL 
• Lane 7- 5 μL 
• Lane 1- 2.5 μL 
• Lane 2- 7.5 μL 
• Lane 3- 7.5 μL 
• Lane 5- 15 μL 
• Lane 6- 15 μL 
• Lane 7- 2.5 μL 
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Proteins were separated according to size. The 1st run was set for 10 minutes at 100 and 200 
mA, the 2nd run was set for 50 minutes at 200 V and 200 mA. Once the running process was 
completed the gels were removed from the glass plates and activated using the Chemidoc™ 
MP Imager System with Image Lab™- 5 software (Bio-Rad, CA, USA) to ascertain whether 
protein loading was equal for all the samples. Hereafter the separated proteins on the gels 
were transferred to membranes. The Trans-Blot® Turbo™ Transfer System (Bio-Rad, CA, 
USA) was utilized to transfer the separated proteins on the gels to Millipore Immobilon®-P 
transfer membranes cut to the appropriate size of the gel. The membranes were sandwiched 
with the gels and placed into the transfer tank with transfer buffer (see Appendix B). The 
transfer took place on ice at 200 V and 200 mA for 55 minutes. Subsequently, the membranes 
were visualized on the ChemiDoc™ to ensure all the proteins had transferred correctly to the 
membranes. Proteins on membranes were then fixed in Methanol for 30 seconds. 
3.9.5 Immunodetection of Proteins 
The membranes were placed on a shaker and blocked for non-specific binding at RT for 2 
hours. Blocking buffer consisted of 95 mL of TBS-Tween (10 % Tris-buffered saline, 0.1% 
Tween- see Appendix B) with 5 mL long life fat-free milk. After blocking, the membranes were 
washed three times using TBS-Tween for 5 minutes each, on the shaker at RT. The 
membranes were then cut and incubated with the primary antibody overnight on the shaker at 
4°C. Anti-DAT was prepared in a 1:1000 dilution with 5%BSA-TBS-Tween (see Appendix B). 
The next day the membranes were washed and incubated with the secondary antibody. The 
membranes were placed on the shaker at RT for 1 hour in anti-Rabbit IgG HRP-linked 
secondary antibody diluted in 5%BSA-TBS-Tween in a 1:2000 dilution. Hereafter the 
membranes were once again washed to remove any unbound antibody and incubated with 
Clarity™ ECL for 5 minutes at RT. Finally, the membranes were exposed using the 
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3.10 Dopamine Treatment 
The effect of dopamine was tested on human sperm parameters in vitro. The effect of high (1 
mM), medium (10 μM) and low (100 nM) concentrations of dopamine compared to a control 
(no dopamine) was tested on human sperm over time. Parameters tested included: Total 
Motility, Progressive Motility; Kinematics, Viability and Acrosome Reaction. Kinematic 
parameters included- curvilinear velocity, VCL, (μm/s); straight-line velocity, VSL, (μm/s); 
average path velocity, VAP, (μm/s); straightness index, STR, (%); linearity index, LIN, (%); 
oscillation index, WOB, (%); amplitude of lateral head displacement, ALH, (μm); and beat-
cross frequency, BCF, (Hz). A total of 24 human semen samples were collected and prepared 
as described in section 3.7.  
 
3.10.1 Preparation of Dopamine concentrations 
Dopamine Hydrochloride is received in powdered form and diluted with PBS to create Stock 
solutions as described in Appendix B . The stocks were aliquoted and stored in Eppendorf’s at 
4°C. 
For experimental procedures, the sample was diluted with correct stock solution to obtain the 
desired final treatment concentrations, in correspondence with what has been used in previous 
studies (Ramírez et al., 2009; Urra et al., 2014), see Appendix B for preparation of dopamine 
treatment concentrations. Dopamine treatment concentrations were, 1 mM, 10 μM and 100 
nM, while the control was PBS with no treatment. The control and treatment groups were 
incubated for 1, 3 and 6 hours. The total motility, progressive motility, kinematics, viability, and 
acrosome reaction was analysed at each time point. An additional time point, 0 minutes, was 
added to record the baseline parameters upon the addition of treatment (see Appendix B). 
 
3.10.2 Assessment of Motility and Kinematic parameters 
Sperm motility is arguably the most important functional parameter of sperm. Spermatozoa 
need to be motile to swim through the female reproductive tract and reach the oocyte. Sperm 
are powered by the flagellum-like tail to propel it towards the egg. Sperm kinematics concern 
the sperm head and its motions during motility. The pattern of velocity of sperm head motions 
are due to the flagellar beat, and therefore may be measured as an assessment of motility. 
Motility parameters was assessed as described in section 3.6.5.1. The CASA analyses a range 
of motility parameters and various Kinematic parameters. At each time point the motility and 
kinematic parameters were measured with the CASA and SCA® system. Total Motility and 
Progressive Motility was measured and expressed as a percentage of Total Motility and a 
percentage of Progressive Motility, respectively. At each time point the CASA and SCA® 
system also automatically captured images of individual spermatozoan head movements and 
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digitally reconstructed their trajectories. The kinematics reported on, includes VCL; VSL; VAP; 
STR; LIN; WOB; ALH and BCF.  
3.10.3 Assessment of Viability 
The viability of spermatozoa is an important parameter of sperm function as it is indicates how 
many live spermatozoa are in a sample or treatment group. The WHO sets a lower reference 
limit of 58% for viable sperm (WHO, 2010). A dye-exclusion staining technique was employed 
to assess the viability of the spermatozoa. Once sperm die, they lose the structural integrity of 
their membranes, therefore they become permeable to stains. Viable sperm remained 
unstained and appeared white under the microscope while non-viable sperm were stained 
pink. Sperm motility also correlates to another parameter, the sperm viability or vitality, 
consequently motile sperm equals viable sperm. 
A mixture of 20 µL Eosin and 30 µL Nigrosin was pipetted into Eppendorf tubes. At each time 
point 10 µL of the sperm sample (control and treatment groups) was added and the solution 
mixed after which smears were created (in duplicate), by pipetting 10 µL of the mixed sample 
onto labelled frosted slides. The slides were allowed to air-dry overnight. Once dried a small 
drop of DPX Mounting medium was added to the slide and a cover slip mounted on top. The 
Nigrosin provides a background stain while the eosin targets damaged (dead) sperm by 
penetrating the membrane. A Nikon Eclipse E200 light microscope was set to 40x 
magnification with a blue filter and contrast setting A. Both the viable and non-viable sperm 
were counted and a minimum of 100 spermatozoa were counted per slide, using a desk 
counter for each group and the results expressed as a percentage of viability. 
3.10.4 Assessment of the Acrosome Reaction 
The acrosome reaction (AR) is a functional parameter of sperm that is crucial for fertilization 
to occur, therefore, it is required to take place at the appropriate time. The use of fluorescein-
conjugated Pisum sativum agglutinin (FITC-PSA) is utilized for its ability to distinguish between 
acrosome intact and acrosome reacted sperm. At each time point 10 µL of the sample was 
pipetted onto labelled frosted slides and smears were made (in duplicate) to dry overnight. 
Once dried the slides were fixed in 95% Ethanol for 30 minutes at 4°C, they are then left to air-
dry.  
In a dark room 450 µL of PBS was added to 50 µL of FITC-PSA and vortexed thoroughly. 10 
µL of this mixture was pipetted onto the air-dried slides and a smear was made. The slides 
were kept in the dark for 45 minutes at RT whereafter they were briefly washed in distilled 
water. The slides were left to air-dry once more. A drop of Dako Fluorescence Mounting 
Medium was placed on the slide and a cover slip mounted on top. The slides were analysed 
with fluorescent microscopy. The slides were viewed under the Nikon Eclipse 50i microscope 
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with the green filter, at 40x magnification, dark field with the FITC filter selected. A minimum of 
100 spermatozoa were counted per slide. Spermatozoa were classified as either intact (when 
the acrosome fluoresced bright green) or reacted (when no acrosome was detected, and the 
spermatozoa appeared dull and empty). Both the acrosome intact and acrosome reacted 
sperm were counted and expressed as a percentage of Acrosome Reacted. 
3.11 Statistical Analysis 
GraphPad™ Prism Version 5.03 (San Diego, USA) was used for all the statistical analyses. 
Results are expressed as the mean ± Standard Deviation (SD). Statistical significance was set 
at P < 0,05. A Two-Way ANOVA was utilized to compare the effects of time and drug 
concentrations on specified variables. Ordinary One-Way ANOVAs were performed, to 
distinguish if the concentration of dopamine influenced sperm parameters over time. The 
recommended normality test’s- Shapiro-Wilk’s and D’Agostino and Pearson omnibus, was 
utilized to determine normality whereafter a One-Way ANOVA or Kruskal Wallis test was 










The results are presented in chronological order, commencing with the indirect 
immunofluorescence images, followed by the western blot images and data. Finally, the 
dopamine treatment’s effect on the various sperm parameters is described in section 4.4. The 
dopamine treatment results are represented graphically while the IF and WB results are 
presented as images. 
 
4.2 Indirect Immunofluorescence 
The DAT protein was detected using an anti-DAT primary antibody, Hoechst as a nuclear stain 
and Alexa Fluor 488 (AF488) as a secondary antibody. As seen in Figure 15E, DAT was found 
to be strongly present in the midpiece region and principal piece of the sperm tail. Furthermore, 
lower, but still visible, DAT fluorescence was observed in the acrosomal region of the 
spermatozoa. When looking at the sperm which were incubated with secondary antibody only, 
(Figure 15A), we observe DAT weak signal in this negative control. This weak signal can be 
attributed to non-specific binding of the AF488. However, the DAT fluorescence in the positive 
control observed (Figure 15D) is strong and thus cannot wholly be attributed to non-specific 
binding. Taking all these factors into account, we can therefore, conclude with a fairly high 
confidence that DAT is found to be present on human sperm membranes (See Appendix D for 
enlarged images).
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Figure 15: Localization of the Dopamine Transporter (DAT) in human sperm, via indirect immunofluorescence (IF) assay. A). Negative control containing only 
AF488 B) Merged image representing Hoechst, DAT and AF488. C) Nuclear stain Hoechst, D). DAT and AF488. E) Magnification of merged image, bar scale 
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4.3 Western Blotting 
Utilization of western blotting techniques generated the following images. For the detection of 
DAT, an anti-DAT primary antibody was used against an anti-Rabbit IgG HRP-linked 
secondary antibody.  
Figure 16 represents the total protein transferred to membrane 1 from gel 1. As seen in Table 
6, lanes 1 and 2 which represent the control samples C1 and C2, respectively, have a much 
higher protein content than lanes 4 and 5 which represents S1 and S2, respectively. This 
discrepancy is noted even though equal loading took place, and all lanes contain equal protein 
content (27 μg) (refer to figure 13). 
 
Figure 16: Membrane 1- Total Protein transferred to membrane. Lane 1 (L1) = C1 brain sample, Lane 
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1 640326050 1655075760 1014749710 
2 722842500 1692226250 969383750 
4 74851006 1061528992 986677986 
5 74796909 1080210654 1005413745 
 
Figure 17 depicts DAT protein expression from both brain (controls) and sperm samples after 
2 seconds of exposure in the ChemiDoc™. Several bands were detected in the positive control 
C1 and C2, with prominent bands at 69 kDa and ~50 kDa. No bands were detected for sperm, 
in both samples, at 2 seconds of exposure. 
 
Figure 17: SDS PAGE and Western Blot analysis for total protein extract (27.5 μg). Membrane 1- DAT 
expression after 2 seconds of exposure. Rat brain (C1 and C2) and human sperm (S1 and S2) with anti-
DAT antibody. 
 
Figure 18 depicts DAT protein expression from both brain (controls) and sperm samples after 
80 seconds of exposure in the ChemiDoc™. Several bands are detected in the positive 
controls, albeit over-exposed, with prominent bands at 69 kDa, 62 kDa and 48 kDa. A faint 
band was detected in S2 at 62 kDa and a darker band at 48 kDa. S1 failed to produce any 
bands after 80 seconds of exposure. The band detected at 62 kDa and 48 kDa in S2 
correspond to the bands in the positive controls C1 and C2. 




Figure 18: SDS PAGE and Western Blot analysis for total protein extract (27.5 μg). Membrane 1- 
DAT expression after 80 seconds of exposure. Rat brain (C1 and C2) and human sperm (S1 and S2) 
with anti-DAT antibody 
 
 
Figure 19 represents the total protein transferred to membrane 2 from gel 2. As seen in Table 
7, lanes 1 and 2 which represent the control samples C1 and C2, respectively, have a much 
higher protein content than lanes 4 and 5 which represents S1 and S2, respectively. This 
discrepancy is noted even though double the volume of sperm sample was loaded, compared 
to the brain sample (refer to figure 14). 




Figure 19: Membrane 2- Total protein transferred to membrane. Lane 1 (L1) = C1 brain sample, Lane 
2 (L2) = C2 brain sample, Lane 4 (L4) = S1 sperm sample, Lane 5 (L5) = S2 sperm sample. 
 











1 490286500 1711259250 1220972750 
2 476212170 1500240525 1024028355 
4 144302528 1280192752 1135890224 
5 164248605 1251198348 1086949743 
 
Figure 20 depicts DAT protein expression from both brain (controls) and sperm samples after 
2 seconds of exposure in the ChemiDoc™. Several bands were detected in the positive 
controls C1 and C2, with prominent bands at 69 kDa and ~50 kDa. No bands were detected 
for sperm, in both samples, at 2 seconds of exposure. 




Figure 20: SDS PAGE and Western Blot analysis for total protein extract (27.5 μg). Membrane 2- DAT 
expression after 2 seconds of exposure. Rat brain (C1 and C2) and human sperm (S1 and S2) with anti-
DAT antibody. 
 
Figure 21 depicts DAT protein expression from both brain (controls) and sperm samples after 
80 seconds of exposure in the ChemiDoc™. Several bands are detected in the positive 
controls, albeit over-exposed, with prominent bands at 69 kDa, 62 kDa and 48 kDa. Two faint 
bands are detected in S1 at 62 kDa and at 48 kDa. A faint band at 62 kDa is detected in S2 
and a darker band is detected at 48 kDa. The band detected at 62 kDa and 48 kDa in the 
sperm samples correspond to the positive controls C1 and C2. 
 
Figure 21: SDS PAGE and Western Blot analysis for total protein extract (27.5 μg). Membrane 2- DAT 
expression after 80 seconds of exposure. Rat brain (C1 and C2) and human sperm (S1 and S2) with 
anti-DAT antibody. 
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4.4 Dopamine Treatments effect on Functional parameters 
The results of the dopamine treatments effect on functional human sperm parameters  are 
described below. A total of 24 sperm samples were collected, treated, and analysed. Total 
Motility, Progressive Motility, Kinematics, Viability and Acrosome Reaction was analysed.  
4.4.1 Total Motility 
Figure 22 depicts a Two-Way ANOVA performed on the Total Motility data; it represents the 
effect of Dopamine on Total Motility of spermatozoa expressed as a percentage over time. The 
WHO sets a lower reference limit of 40% for Total Motility. An expected time dependent 
decrease of Total Motility is observed, this is an expected observation in in vitro experiments, 
however this is greatly exacerbated by the addition of the high concentration of dopamine. As 
shown in figure 22, dopamine had a significant effect on total motility specifically at the high 
concentration of 1 mM. The high concentration of dopamine is shown to significantly decrease 
Total Motility as early as 60 minutes when compared to the control (51.99% ± 15.93 vs. 18.10% 
± 8.75). The low and medium concentrations did not significantly affect Total Motility at any 
time point when compared to the controls. 
 
Figure 22: Effect of different concentrations of dopamine on Total Motility over time. n = 24 Two-Way 
ANOVA ***P<0.001, **P<0.01, *P<0.05  
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Figure 23 depicts the effect of Dopamine at different concentrations on Total Motility expressed 
as a percentage over time. One-Way analysis of variance was performed and either Dunn’s 
Multiple Comparison or Bonferroni’s Multiple Comparison test was performed. In Figure 23A, 
it is clear to see that Total Motility decreases significantly as time progresses without any 
treatment present (51.27% ± 15.44 vs. 31.14% ± 17.47), however this is expected as sperm 
lose motility over time. Figure 23B depicts the effect of the low (100 nM) concentration of 
dopamine over time. Time significantly affected the decrease of Total Motility. Figure 23C 
depicts the effect of the medium (10 μM) concentration of dopamine over time. Once again, a 
significant decrease is observed when comparing all the time points to 360 minutes. Figure 
23D depicts the effect of the high concentration of dopamine over time. The high concentration 
significantly decreased the total motility at 60 minutes (44.30% ± 12.72 vs. 18.75% ± 8.75), at 
180 minutes (44.30% ± 12.72 vs. 12.83% ± 6.498) and at 360 minutes (44.30% ± 12.72 vs. 
10.46% ± 6.715) when compared to time 0. 




Figure 23: Effect of time at different concentrations of dopamine on Total Motility (A) Total Motility of 
Control. (B) Total Motility at a Low (100 nM) concentration of dopamine. (C) Total Motility at a Medium 
(10 μM) concentration of dopamine. (D) Total Motility at a High (1 mM) concentration of dopamine. 
***P<0.001, **P<0.01, *P<0.05 n = 24 
 
4.4.2 Progressive Motility 
Figure 24 depicts a Two-Way ANOVA performed on the Progressive Motility data; it represents 
the effect of Dopamine on Progressive Motility of spermatozoa expressed as a percentage 
over time. The WHO sets a lower reference limit of 32% for Progressive Motility. Similarly to 
Total Motility a time-dependent decrease is observed for Progressive Motility, which is 
significantly exacerbated by the high concentration of dopamine. The high concentration of 
dopamine is shown to significantly decrease Progressive Motility as early as 60 minutes when 
compared to the control (39.03% ± 13.50 vs. 7.296% ± 4.578). Both the low and medium 
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concentrations of dopamine do not significantly affect the Progressive Motility at any time point 
when compared to controls. 
 
Figure 24: Effect of different concentrations of dopamine on Progressive Motility over time. n = 24 
Two-Way ANOVA ***P<0.001, **P<0.01, *P<0.05 
 
Figure 25 depicts the effect of Dopamine on Progressive Motility expressed as a percentage 
over time. One-Way analysis of variance was performed and either Dunn’s Multiple 
Comparison or Bonferroni’s Multiple Comparison test was performed. In Figure 25A, it is clear 
to see that Progressive Motility decreases significantly as time progresses without any 
treatment present (31.12% ± 12.66 vs 19.47% ± 13.24). Figure 25B depicts the effect of the 
low (100 nM) concentration of dopamine over time. Progressive Motility was significantly 
affected by time. Figure 25C depicts the effect of the medium (10 μM) dopamine concentration 
over time. At 6 hours the Progressive Motility was significantly decreased. Figure 25D 
represents the % Progressive Motility over time at the high dopamine concentration. The high 
concentration significantly decreased the Progressive Motility as early as 60 minutes (29.05% 
± 10.48 vs 6.150% ± 4.578) when compared to time 0. At 180 minutes the decrease was also 
significant (29.05 ± 10.48 vs 5.945 ± 3.416). The high concentration decreased the Progressive 
Motility from 29.05% at 0 minutes to 4.82% at 360 minutes. 




Figure 25: Effect of time at different concentrations of dopamine on Progressive Motility(A) Progressive 
Motility of Control. (B) Progressive Motility at a Low (100 nM) concentration of dopamine. (C) 
Progressive Motility at a Medium (10 μM) concentration of dopamine. (D) Progressive Motility at a High 
(1 mM) concentration of dopamine. ***P<0.001, **P<0.01, *P<0.05 n = 24 
 
 




Kinematic analysis of sperm movement within a sample measures the velocity, acceleration, 
and displacement of spermatozoa. The velocity and trajectory of the sperm determine motility 
and are therefore important to characterise. The velocity parameters include the Curvilinear 
Velocity (VCL), the Straight-line Velocity (VSL), and the Average Path Velocity (VAP), these 
are all measured as speeds (μm/s). The trajectory of a spermatozoa can influence the velocity 
values; therefore, the velocity values are compared by ratios that have been derived (Mortimer 
and Mortimer, 1990). The Linearity Index (LIN %) is derived by (VSL/VCL) x 100; the 
Straightness Index (STR %) is calculated as (VSL/VAP) x 100; and the Oscillatory Index (WOB 
%) is calculated as (VAP/VCL) x 100. The Amplitude of Lateral Head Displacement (ALH) 
measures the degree of lateral displacement of the sperm head around its average path and 
is measured in μm (Ayad, Van der Horst and Du Plessis, 2018). The Beat-Cross Frequency 
(BCF) describes the frequency at which the sperm head crosses the average path, it is 
measured in Hz (Ayad, Van der Horst and Du Plessis, 2018). Since the pattern of velocity of 
sperm head motion is due to the flagellar beat, it may therefore be measured as an assessment 
of motility (Kay and Robertson, 1998). 
 
4.4.3.1 VCL 
Figure 26 represents a Two-Way ANOVA performed on the Kinematic parameter Curvilinear 
Velocity (VCL). It depicts the effect of dopamine on VCL over time expressed as speed per 
second (μm/s). As seen in figure 26 the VCL is significantly affected by the high concentration 
of dopamine. VCL decreases gradually over time but the decrease is significantly exacerbated 
by the high concentration of dopamine at each time point when compared to the controls, time 
0 (101.2 ± 12.18 vs. 91.42 ± 10), 1 hour (102.8 ± 12.67 vs. 61.66 ± 7.073), 3 hours (92.73 ± 
15.97 vs. 67.23 ± 5.297) and 6 hours (78.08 ± 10.95 vs. 68.45 ± 5.129). 




Figure 26: Effect of different concentrations of dopamine on Curvilinear Velocity (VCL) over time. n= 
24 Two-Way ANOVA ***P<0.001, **P<0.01, *P<0.05 
 
Figure 27 depicts the effect of Dopamine on VCL expressed as a speed (μm/s) over time. One-
Way analysis of variance was performed and either Dunn’s Multiple Comparison or 
Bonferroni’s Multiple Comparison test was performed. Figure 27A represents the effect of the 
control on VCL, as seen VCL significantly decreases over time (101.2 ± 12.18 vs 78.08 ± 
10.95) when no treatment is present. Figure 27B depicts the effect of low dopamine 
concentration on VCL. Time significantly affected the decrease of VCL. Figure 27C depicts the 
effect of the medium concentration of dopamine on VCL. A time-dependent decrease is 
observed from time 0 to 6 hours; however, the decrease is significantly exacerbated after 3 
hours (87.29 ± 16.16 vs. 71.94 ± 8.601). Figure 27D depicts the effect of the high concentration 
of dopamine on VCL. As in figure 28D the high concentration of dopamine significantly 
decreases VCL from as early as 60 minutes (102.8 ± 12.67 vs. 62.66 ± 7.073) when compared 
to the control at 60 minutes. 




Figure 27: Effect of time at different concentrations of dopamine on Curvilinear Velocity (VCL) (A) VCL 
of Control. (B) VCL at a Low (100 nM) concentration of dopamine. (C) VCL at a Medium (10 μM) 
concentration of dopamine. (D) VCL at a High (1 mM) concentration of dopamine. ***P<0.001, **P<0.01, 
*P<0.05 n = 24 
 
4.4.3.2 VAP 
Figure 28 represents a Two-Way ANOVA performed on the Kinematic parameter Average 
Path Velocity (VAP). It depicts the effect of dopamine on VAP over time expressed as speed 
per second (μm/s). Figure 28 shows that the high concentration of dopamine significantly 
decreased the VAP at 1, 3 and 6 hours when compared to the control, low and medium 
concentrations of dopamine. After 1 hour of incubation the high concentration decreased the 
VAP (control) from 61.25 ± 8.283 to 30.89 ± 5.233. 




Figure 28: Effect of different concentrations of dopamine on Average Path Velocity (VAP) over time. n 
= 24 Two-Way ANOVA ***P<0.001, **P<0.01, *P<0.05  
 
Figure 29 depicts the effect of dopamine on VAP expressed as a speed (μm/s) over time. One-
Way analysis of variance was performed and either Dunn’s Multiple Comparison or 
Bonferroni’s Multiple Comparison test was performed. Figure 29A depicts the effect of the 
control on VAP. An expected time-dependent decrease is observed in the absence of 
treatment. Figure 29B and 29C depicts the effect of the low and medium concentrations, 
respectively of dopamine on VAP. A significant time-dependent decrease is observed for VAP 
for both the low and medium concentrations of dopamine. Figure 29D depicts the effect of the 
high concentration of dopamine on VAP. As seen in figure 29D the high concentration of 
dopamine significantly decreases VAP after 1 hour of incubation (61.25 ± 8.283vs.30.89 ± 
5.233) when compared to the control at 60 minutes. 




Figure 29: Effect of time at different concentrations of dopamine on Average Path Velocity (VAP) (A) 
VAP of Control. (B) VAP at a Low (100 nM) concentration of dopamine. (C) VAP at a Medium (10 μM) 
concentration of dopamine. (D) VAP at a High (1 mM) concentration of dopamine. ***P<0.001, **P<0.01, 
*P<0.05 n = 24 
 
4.4.3.3 VSL 
Figure 30 represents a Two-Way ANOVA performed on the Kinematic parameter Straight-Line 
Velocity (VSL). It depicts the effect of dopamine on VSL over time expressed as speed per 
second (μm/s). From figure 30 it can be seen that high concentrations significantly decreased 
the VSL at 1, 3 and 6 hours, when compared to the control, low and medium concentrations 
of dopamine. After 1 hour of incubation with the high concentration of dopamine the VSL 
(control) was decreased from 42.92 ± 7.838 to 13.07 ± 4.379. 




Figure 30: Effect of different concentrations of dopamine on Straight-line Velocity (VSL) over time. n = 
24 Two-Way ANOVA ***P<0.001, **P<0.01, *P<0.05 
 
Figure 31 depicts the effect of dopamine on VSL expressed as a speed (μm/s) over time. One-
Way analysis of variance was performed and either Dunn’s Multiple Comparison or 
Bonferroni’s Multiple Comparison test was performed. Figure 31A represents the effect of the 
control on VSL, as seen VSL decreases significantly as time progresses (42.26 ± 7.716 vs. 
27.05 ± 11.59). Figures 31B and 31C depicts the low concentration and medium 
concentrations of dopamine on VSL, respectively. The low and medium concentrations did not 
significantly affect the VSL, however, a time-dependent decrease is observed. Figure 31D 
depicts the high concentration of dopamine on VSL over time. As seen, VSL is significantly 
decreased after 1 hour of incubation with the high concentration (40.26 ± 7.68 vs. 13.07 ± 
4.379) when compared to time 0. 




Figure 31: Effect of time at different concentrations of dopamine on Straight-line Velocity (VSL). (A) 
VSL of Control. (B) VSL at a Low (100 nM) concentration of dopamine. (C) VSL at a Medium (10 μM) 
concentration of dopamine. (D) VSL at a High (1 mM) concentration of dopamine. ***P<0.001, 
**P<0.01, *P<0.05 n = 24 
 
4.4.3.4 STR 
Figure 32 represents a Two-Way ANOVA performed on the Kinematic parameter Straightness 
Index (STR). It depicts the effect of dopamine on STR over time expressed as a percentage 
over time. From figure 32 it can be seen that the high concentration significantly decreases the 
STR % at 1, 3 and 6 hours when compared to the control, low and medium concentrations of 
dopamine. After 1 hour of incubation with the high concentration of dopamine the STR (control) 
decreased from 62.23% ± 4.622 to 39.63% ± 6.781. 




Figure 32: Effect of different concentrations of dopamine on Straightness Index (STR) over time. n = 24 
Two-Way ANOVA ***P<0.001, **P<0.01, *P<0.05 
 
Figure 33 depicts the effect of dopamine on STR expressed as a percentage over time. One-
Way analysis of variance was performed and either Dunn’s Multiple Comparison or 
Bonferroni’s Multiple Comparison test was performed. Figure 33A depicts the effect of the 
control on STR. As seen in Figure 33A the STR decreases significantly over the 6 hours, 
without treatment present (62.23% ± 4.081 vs.53.70% ± 9.129). Figures 33B and 33C depict 
the effect of the low and medium concentrations of dopamine of STR, respectively. As seen in 
these figures, a significant time-dependent decrease is observed. However, as seen in Figure 
33D, the high concentration significantly decreases STR from as early as 1 hour when 
compared to time 0 (63.71% ± 5.962 vs. 39.63% ± 6.781). 




Figure 33: Effect of time at different concentrations of dopamine on Straightness Index (STR). (A) 
STR of Control. (B) STR at a Low (100 nM) concentration of dopamine. (C) STR at a Medium (10 μM) 
concentration of dopamine. (D) STR at a High (1 mM) concentration of dopamine. ***P<0.001, 
**P<0.01, *P<0.05 n = 24 
 
4.4.3.5 LIN 
Figure 34 represents a Two-Way ANOVA performed on the Kinematic parameter Linearity 
Index (LIN). It depicts the effect of dopamine on LIN over time expressed as a percentage over 
time. As seen in figure 34 the high concentration significantly decreases the LIN % at 1, 3 and 
6 hours when compared to the control, low and medium concentrations of dopamine. After 1 
hour of incubation with the high concentration of dopamine the LIN is significantly decreased 
when compared to the control at 60 minutes (38.79% ± 4.230 vs. 21.07% ± 5.510). 




Figure 34: Effect of different concentrations of dopamine on Linearity Index (LIN) over time. n = 
24Two-Way ANOVA ***P<0.001, **P<0.01, *P<0.05 
 
Figure 35 depicts the effect of dopamine on LIN expressed as a percentage over time. One-
Way analysis of variance was performed and either Dunn’s Multiple Comparison or 
Bonferroni’s Multiple Comparison test was performed. Figure 35A depicts the effect of the 
control on LIN over time. As seen a significant time-dependent decrease is observed in the 
absence of treatment (39.24% ± 5.826 vs. 32.28% ± 8.784). Figures 35B and 35C depict effect 
of the low and medium concentrations of dopamine on LIN, respectively. Once again, a time-
dependent decrease is observed. However, in Figure 35D, which depicts the effect of the high 
concentration of dopamine on LIN over time, a significant decrease is observed as early as 1 
hour when compared to time 0 (41.33% ± 6.796 vs. 21.07% ± 5.51). 
 




Figure 35: Effect of time at different concentrations of dopamine on Linearity Index (LIN). (A) LIN of 
Control. (B) LIN at a Low (100 nM) concentration of dopamine. (C) LIN at a Medium (10 μM) 
concentration of dopamine. (D) LIN at a High (1 mM) concentration of dopamine. ***P<0.001, 
**P<0.01, *P<0.05 n = 24 
 
4.4.3.6 WOB 
Figure 36 represents a Two-Way ANOVA performed on the Kinematic parameter Oscillatory 
Index (WOB). It depicts the effect of dopamine on WOB over time expressed as a percentage 
over time. From figure 36 it can be seen that the high concentration significantly decreases the 
WOB % at 1, 3 and 6 hours when compared to the control, low and medium concentrations of 
dopamine. As seen in Figure 36 the high concentration of dopamine significantly decreases 
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the WOB from as early as 1 hour when compared to the control at 60 minutes (59.02% ± 3.8 
vs. 49.66% ± 5.09). 
 
 
Figure 36: Effect of different concentrations of dopamine on Oscillatory Index (WOB) over time. n = 24 
Two-Way ANOVA ***P<0.001, **P<0.01, *P<0.05 
 
Figure 37 depicts the effect of dopamine on WOB expressed as a percentage over time. One-
Way analysis of variance was performed and either Dunn’s Multiple Comparison or 
Bonferroni’s Multiple Comparison test was performed. Figure 37A depicts the effect of the 
control on WOB over time. As seen in Figure 37A, a significant time-dependent decrease is 
observed in the absence of treatment after 3 hours (59.55% ± 4.629 vs. 55.42% ± 6.042). 
Figures 37B and 37C depicts the effect of the low and medium concentrations of dopamine on 
WOB, respectively. As seen in these figures time significantly decreases the WOB, although 
after 3 hours the decrease is exacerbated. Figure 37D depicts the effect of the high 
concentration of dopamine on WOB over time, and as seen WOB is significantly decreased 
after 1 hour of incubation when compared to time 0 (60.80% ± 5.112 vs. 49.66% ± 5.09). 




Figure 37: Effect of time at different concentrations of dopamine on Oscillatory Index (WOB). (A) 
WOB of Control. (B) WOB at a Low (100 nM) concentration of dopamine. (C) WOB at a Medium (10 
μM) concentration of dopamine. (D) WOB at a High (1 mM) concentration of dopamine. ***P<0.001, 
**P<0.01, *P<0.05 n = 24 
 
4.4.3.7 ALH 
Figure 38 represents a Two-Way ANOVA performed on the Kinematic parameter Amplitude 
of Lateral Head Displacement (ALH). It depicts the effect of dopamine on ALH over time 
expressed as distance covered over time (μm). It is seen in figure 38 that the high 
concentration significantly decreases the ALH at time 0, 1 hour and 3 hours, when compared 
to the control, low and medium concentrations of dopamine. At 6 hours the ALH is not 
significantly affected. After the addition of dopamine, at time 0, the high concentration 
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significantly decreases the ALH when compared to the control (2.547 ± 0.2968 vs. 2.313 ± 
0.2475). 
 
Figure 38: Effect of different concentrations of dopamine on Amplitude of Lateral Head Displacement 
(ALH) over time. n = 24 Two-Way ANOVA ***P<0.001, **P<0.01, *P<0.05 
 
Figure 39 depicts the effect of dopamine on ALH expressed as a distance covered over time. 
One-Way analysis of variance was performed and either Dunn’s Multiple Comparison or 
Bonferroni’s Multiple Comparison test was performed. Figure 39A depicts the effect of the 
control on ALH, as seen in this figure ALH is significantly decreased in the absence of 
treatment, however the decrease is exacerbated after 3 hours of incubation (2.371 ± 0.2123 
vs. 2.169 ± 0.1522). The same effect is observed in Figures 39B and 39C, which depict the 
effect of the low and medium concentration of dopamine on ALH, respectively. Figure 39D 
depicts the effect of the high concentration of dopamine, an initial significant decrease is 
observed after 1 hour of incubation when compared to time 0 (2.313 ± 0.2475 vs. 1.931 ± 
0.1681), however the ALH increases significantly after 1 hour of incubation (1.931 ± 0.1681 
vs. 2.119 ± 0.1622). 




Figure 39: Effect of time at different concentrations of dopamine on Amplitude of Lateral Head 
Displacement (ALH). (A) ALH of Control. (B) ALH at a Low (100 nM) concentration of dopamine. (C) 
ALH at a Medium (10 μM) concentration of dopamine. (D) ALH at a High (1 mM) concentration of 
dopamine. ***P<0.001, **P<0.01, *P<0.05 n = 24 
 
4.4.3.8 BCF 
Figure 40 represents a Two-Way ANOVA performed on the Kinematic parameter Beat-Cross 
Frequency (BCF). It depicts the effect of dopamine on BCF over time expressed as a frequency 
over time (Hz). From figure 40 it can be seen that the high concentration significantly decreases 
the BCF at 1, 3 and 6 hours when compared to the control, low and medium concentrations of 
dopamine. After 1 hour of incubation the high concentration of dopamine significantly 
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decreases the BCF when compared to the control at 60 minutes (12.8 ± 1.569 vs. 5.54 ± 
1.675). 
 
Figure 40: Effect of different concentrations of dopamine on Beat-Cross Frequency (BCF) over time. n 
= 24 Two-Way ANOVA ***P<0.001, **P<0.01, *P<0.05 
 
Figure 41 depicts the effect of dopamine on BCF expressed as a frequency over time. One-
Way analysis of variance was performed and either Dunn’s Multiple Comparison or 
Bonferroni’s Multiple Comparison test was performed. Figure 41A depicts the effect of the 
control on BCF over time, as seen in this figure a significant time-dependent decrease is 
observed in the absence of treatment, however after 3 hours this decrease is exacerbated 
(12.29 ± 3.227 vs. 8.803 ± 3.085). The same effect is observed in Figures 41B and 41C, which 
represent the effect of the low and medium concentrations of dopamine on BCF, respectively. 
However, as seen in Figure 41D, which depicts the effect of the high concentration of dopamine 
on BCF over time, a significant decrease can be observed as early as 1-hour when compared 
to time 0 (12.49 ± 1.58 vs. 5.54 ± 1.675). 




Figure 41: Effect of time at different concentrations of dopamine on Beat-Cross Frequency (BCF). (A) 
BCF of Control. (B) BCF at a Low (100 nM) concentration of dopamine. (C) BCF at a Medium (10 μM) 
concentration of dopamine. (D) BCF at a High (1 mM) concentration of dopamine. ***P<0.001, 
**P<0.01, *P<0.05 n = 24 
 
4.4.4 Viability 
The sample size for viability (performed via a dye-exclusion technique) was 22, as 2 donors 
viability data (slides) could not be analysed due to damage. Figure 42 depicts a Two-Way 
ANOVA performed on the Viability data; it represents the effect of dopamine on Viability of 
spermatozoa expressed as the percentage of viable sperm over time. As seen in figure 42 
Dopamine had a significant effect on viability specifically at the high concentration of 1 mM. 
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The high concentration of dopamine is shown to significantly decrease viability as early as 60 
minutes, when compared to the control (55.78% ± 4.491 vs. 49.03% ± 7.704). At 3 and 6 
hours the viability is significantly decreased by the high concentration of dopamine when 
compared to the control, low and medium concentrations. At 6 hours the viability of the 
sperm, when exposed to the high concentration of dopamine, is decreased to 17.89% ± 
14.82 from 46.20% ± 8.510. 
 
Figure 42: Effect of different concentrations of dopamine on Viability over time. n = 22 Two-Way ANOVA 
***P<0.001, **P<0.01, *P<0.05 
 
Figure 43 depicts the effect of dopamine at different concentrations on Viability expressed as 
a percentage over time. One-Way analysis of variance was performed and either Dunn’s 
Multiple Comparison or Bonferroni’s Multiple Comparison test was performed. In Figure 43A, 
it is clear to see that Viability decreases significantly as time progresses without any treatment 
present (54.57% ± 6.030 vs 46.20% ± 8.510), however this is expected as sperm die over time. 
Figure 43B depicts the effect of the low concentration of dopamine over time. Time significantly 
affected the decrease of viability. Figure 43C depicts the effect of the medium concentration 
of dopamine over time. Once again, a significant decrease is observed when comparing the 
all the time points to 360 minutes. Figure 43D depicts the effect of the high concentration of 
dopamine over time. The high concentration significantly decreased the viability at 180 minutes 
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(51.86% ± 7.220 vs 34.36% ± 13.03), and at 360 minutes (46.20% ± 8.51 vs 17.89% ± 14.82) 
when compared to the controls. 
 
Figure 43: Effect of time at different concentrations of dopamine on Viability. (A) Viability of Control. (B) 
Viability at a Low (100 nM) concentration of dopamine. (C) Viability at a Medium (10 μM) concentration 
of dopamine. (D) Viability at a High (1 mM) concentration of dopamine. ***P<0.001, **P<0.01, *P<0.05 
n = 22 
 
4.4.5 Acrosome Reaction 
The sample size for exploring the acrosome reaction was only 17, as 7 donors acrosome data 
(slides) could not be analysed due to damage. Figure 44 depicts a Two-Way ANOVA 
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performed on the Acrosome Reaction data, expressed as a percentage of acrosome reacted 
sperm over time. As seen in figure 44 the acrosome reaction is elicited prematurely as time 
progresses, however, at time 0, upon addition of the treatment, both the medium (26.88% ± 
3.199 vs. 31.21% ± 3.464) and high (26.88% ± 3.199 vs. 31.91% ± 2.852) concentrations of 
dopamine exacerbated the effect of premature acrosome reaction when compared to the 
control. At 3 hours the high concentration significantly increased the amount of acrosome 
reacted sperm compared to the control. At 6 hours the high concentration significantly affected 
the acrosome reaction compared to the control, low and medium concentration. The high 
concentration of dopamine elicited 45.37% ± 5.940 of acrosome reactions after 6 hours of 
incubation, much higher than the control at 6 hours (37.85% ± 5.358). 
 
Figure 44: Effect of different concentrations of dopamine on Acrosome Reaction over time. n = 17 Two-
Way ANOVA ***P<0.001, **P<0.01, *P<0.05 
 
Figure 45 depicts the effect of different concentrations of dopamine on Acrosome Reaction 
expressed as a percentage of acrosome reacted sperm over time One-Way analysis of 
variance was performed and either Dunn’s Multiple Comparison or Bonferroni’s Multiple 
Comparison test was performed. Figure 45A depicts the baseline of the acrosome reaction 
when no treatment was added (control). As time progressed the acrosome reaction was 
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elicited, as expected. Figure 45B depicts the effect of low concentrations of dopamine on 
acrosome reaction, it would seem time significantly increased the percentage of acrosome 
reacted sperm. Figure 45C depicts the effect of the medium concentration of dopamine on 
acrosome reaction, the acrosome reaction is increased significantly from 3 hours onwards, 
when compared to time 0 (31.21% ± 3.464 vs. 37.53% ± 4.695) and 1 hour (32.29% ± 3.849 
vs. 37.53% ± 4.695). Figure 45D depicts the effect of the high concentration of dopamine on 
acrosome reaction. The high concentration significantly increases the acrosome reaction at 3 
hours (33.68% ± 5.434 vs 38.18% ± 5.391) and at 6 hours (37.85% ± 5.358 vs 45.37% ± 5.940) 
when compared to the control. 
 
Figure 45: Effect of time at different concentrations of dopamine on Acrosome Reaction. (A) Acrosome 
Reaction of Control. (B) Acrosome Reaction at a Low (100 nM) concentration of dopamine. (C) 
Acrosome Reaction at a Medium (10 μM) concentration of dopamine. (D) Acrosome Reaction at a High 
(1 mM) concentration of dopamine. ***P<0.001, **P<0.01, *P<0.05 n = 17 
 






The first aim of the current study was to identify the Dopamine Transporter (DAT) on human 
sperm membranes. The DAT was identified by an indirect immunofluorescence assay and its 
presence was confirmed using western blotting analyses. Secondly,  the study aimed to 
investigate the effects of dopamine on human sperm parameters such as motility, viability, and 
acrosome reaction. This study aimed to focus on the effects of the dopaminergic pathway in 
the functions of human sperm and to elucidate possible mechanisms through which it may act 
to bring about any possible changes. Various objectives have been utilized to achieve the aims 
set out and the results thereof will be discussed in this chapter. 
The presence of DAT on mammalian sperm membranes, including human, mouse, bull and 
horse  has previously been investigated by indirect IF techniques, however, Ramírez et al., 
(2009) focused on the discovery of DAT in boar spermatozoa and only included the other 
species mentioned above, including humans, in supplementary data. Boar sperm displayed a 
strong immunoreaction in the principal piece of the sperm (Ramírez et al., 2009). Similarly, 
Urra et al., (2014) positively identified a functional DAT in equine sperm via indirect IF, with a 
strong immunoreaction in the acrosomal region. From the immunofluorescence assay results 
as performed in the current study, a strong immunoreaction was found in the positive controls, 
while the negative controls elicited a rather weak immunoreaction. Thus, from the IF 
micrographs it is evident that the study wasable to identify and show the presence and 
localization, with fairly high certainty, of DAT on human sperm membranes.  These findings 
are in accordance with previous studies mentioned above, with our findings being the first to 
focus on human spermatozoa.  
Two studies previously investigated the presence of DAT on sperm membranes using WB 
techniques; Ramírez et al., (2009) presented findings that boar sperm expresses DAT at ~75 
kDa; Urra et al., (2014) mainly focused on the identification of a functional DAT in equine 
spermatozoa, appearing on WB membranes at ~70 kDa. However, these authors also included 
supplementary data which suggests that boar, human, and bull spermatozoa also possess a 
DAT with a molecular weight of ~70 kDa (Ramírez et al., 2009; Urra et al., 2014). DAT is a 
glycoprotein located in cell membranes with a molecular weight of approximately 60-80 kDa 
when found in its native form. Our findings for the western blotting analyses showed that two 
protein bands with molecular weights of 62 kDa and 48 kDa are present in human sperm, 
which correlate to the bands found in the positive control (rat brain tissue). As seen in figures 
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18 and 21 of Chapter 4, the positive controls display numerous protein bands, with prominent 
bands at 69 kDa, 62 kDa and 48 kDa. DAT has been shown to form dimers, trimers, and 
tetramers in neuronal membranes of mammalian species such as canines, rats, and humans 
(Hastrup, Karlin and Javitch, 2001; Hastrup, Sen and Javitch, 2003; Pramod et al., 2013; 
Cheng et al., 2019). The heterogeneity observed within the brain could be due to homo-
oligomerization, hetero-oligomerization of DAT with the D2 receptor or the different degrees of 
glycosylation of DAT. Photoaffinity labelling of neuronal DATs in canines showed that it 
presents as a polypeptide with an apparent weight of 62 kDa on WB membranes and 
possesses multiple glycosylation sites (Sallee et al., 1989). However complete N-link 
deglycosylation of the neuronal DAT with PNGase-F, an endoglycosidase, decreased the 
molecular weight on WB membranes to approximately 48 kDa (Sallee et al., 1989). It was 
suggested that the 48 kDa protein could represent the ligand binding subunit of DAT (Sallee 
et al., 1989). Brain specific differences were observed in rats, where DAT was expressed at 
~76 kDa in the striatum but presented with at slightly lower molecular weight band in the 
nucleus accumbens; this size difference in molecular weight was attributed to the degree of 
glycosylation in the different brain regions (Lew et al., 1992). Since whole rat brain extracts 
were utilized as controls in this study it could be postulated that the high degree of 
heterogeneity observed could be attributed to the differential expression of DAT in various 
brain regions, as suggested by previous authors. 
DAT structurally possess three N-linked glycosylation sites on the 2nd extracellular loop and Li 
et al., (2004) observed through site-directed mutagenesis that N-linked mutant DATs from 
human substantia nigra migrate to different molecular weights on WB membranes. Upon 
removal of one of these glycosylation sites (treated with N-glycanase to yield a single mutant), 
the wild-type DAT from neuronal membranes migrated from ~75 kDa to a broad band of ~62 
kDa. In addition, it displayed an additional discrete band at ~49 kDa. The double mutant DAT 
(after removal of two glycosylation sites) displayed a broad band at ~58 kDa and an additional 
discrete band at ~48 kDa. Finally, the triple mutant (removal of all three glycosylation sites) 
yielded a broad band at ~45 kDa and a more discrete band at ~39 kDa. These authors 
concluded that these results suggest that each glycosylation site for DAT is approximately 10 
kDa in length, which falls within the range previously demonstrated for the norepinephrine 
transporter (Melikian et al., 1996; Nguyen and Amara, 1996; Li et al., 2004). Glycosylation 
patterns may vary substantially depending on the cell type, the glycoprotein is produced in, 
and the physiological state in which the cell is in (Lis and Sharon, 1993). The sperm samples 
S1 and S2 present faint bands at 62 kDa and 48 kDa as seen in Chapter 4 figures 18 and 21. 
We conclude that both these bands represent DAT, albeit differentially glycosylated. Thus, 
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from the WB results the study was able to confirm the results found in the IF assay, which 
show DAT to be present on human sperm membranes. 
Sperm comprises of a head, and a flagellum. The flagellum can be divided into four distinct 
regions namely, the neck, the midpiece, the principal piece and the end piece (Cummins and 
Woodall, 1985; Gu et al., 2019). The midpiece is comprised of the mitochondrial sheath, which 
contains numerous tightly packed mitochondria (Lindemann and Lesich, 2016; Gu et al., 2019). 
The mitochondrial sheath is about 1.5 times as long as the sperm head; in bull spermatozoa, 
it is 11 μm in length (Lindemann and Lesich, 2016; Rothmann and Bort, 2018). The 
mitochondrial sheath is about 80 nm thick and lies directly beneath the plasma membrane. It 
is believed to be an important energy source, essential for sperm motility (Piomboni et al., 
2012; Briz and Fàbrega, 2013; Carrillo, 2016; Ayad, Van der Horst and Du Plessis, 2018). The 
principal piece is located just beneath the midpiece and comprises of a fibrous sheath which 
measures ~40 μm in length (Carrillo, 2016; Lindemann and Lesich, 2016; Rothmann and Bort, 
2018). The fibrous sheath lies beneath the plasma membrane and acts as a scaffold for 
proteins involved in the regulation of sperm motility (Eddy, Toshimori and O’Brien, 2003; 
Turner, 2003). It was shown that the fibrous sheath also possesses glycolytic enzymes to 
supply energy for movement, implying mitochondrial oxidative phosphorylation within the 
sperm midpiece to not be the only mechanism behind sperm motility (Turner, 2006). 
The human sperm head is approximately 4-5.5 µm long and 3 µm wide (Cummins and 
Woodall, 1985; Rothmann and Bort, 2018). The head comprises of the nucleus, a limited 
amount of cytoplasm a few cytoskeletal structures, and the acrosome (Toshimori and Ito, 
2003). The acrosome, a Golgi-derived cap, sits on the anterior portion of the sperm head and 
it is surrounded by an outer and inner acrosomal membrane (Aguas and Da Silva, 1985; 
Toshimori and Ito, 2003; Fléchon, 2016). The acrosome contains specific enzymes such as 
the proteolytic enzyme Acrosin and plays a key role in gamete fusion by facilitating the 
spermatozoa to penetrate the zona pellucida and fuse with the oocyte (Schill, Töpfer-Petersen 
and Heissler, 1988; Brucker and Lipford, 1995; Breitbart and Spungin, 1997; Fléchon, 2016). 
The acrosome reaction is a Ca2+-dependent exocytotic process and it is essential that the 
acrosome reaction does not occur before the required time, as spermatozoa whose acrosomes 
have reacted prematurely will not be able to fertilize an oocyte (Brucker and Lipford, 1995; 
Breitbart and Spungin, 1997; Yanagimachi, 2011).The acrosome reaction will only occur once 
the spermatozoa has undergone capacitation and it is the steps of the capacitation process 
which ultimately lead to the acrosome reaction taking place (Breitbart and Spungin, 1997; 
Breitbart, 2002; Carlson, Hille and Babcock, 2007). In the current study a weak 
immunoreaction was detected in the acrosomal region of the spermatozoa. Previously equine 
sperm displayed a strong DAT fluorescence in the acrosomal region (Urra et al., 2014). The 
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acrosomal integrity of sperm was significantly decreased upon the addition of both the medium 
and high concentrations of dopamine as observed in figure 45 in Chapter 4. Furthermore after 
3 hours of incubation with the high concentration of dopamine the acrosome reaction was 
significantly prematurely elicited when compared to the controls.  
Ca2+- mediated signalling mechanisms have been implicated in multiple functions within 
sperm. An increase in intracellular Ca2+, through calcium channels situated on sperm 
membranes (as well as intracellular stores), increase cAMP production, and thus activates 
PKA to phosphorylate sperm tail proteins such as A-kinase anchoring protein 3 (AKAP-3), 
found within the fibrous sheath of the sperm tail (Darszon et al., 2006; Carlson, Hille and 
Babcock, 2007; Leahy and Gadella, 2011; Correia, Michelangeli and Publicover, 2015; Vizel 
et al., 2015; Carrillo, 2016). PKA phosphorylation of sperm tail proteins activate the ATPase, 
and the energy released from the ATP hydrolysis is transformed into movement (Tash, 1989; 
Turner, 2006). Tyrosine phosphorylation through activation by PKA has been shown to be 
crucial in the modulation and induction of sperm motility and the regulation of capacitation and 
acrosome reaction (Visconti et al., 1995a; Visconti et al., 1995b; Tash and Bracho, 1998; 
Turner, 2006; Vizel et al., 2015). Sperm motility is generally accepted as the central component 
of normal male fertility as it is essential for the fertilization of oocytes (Turner, 2006; Malik et 
al., 2011). Spermatozoa achieve motility once ejaculated and it is the presence of the HCO3- 
in the seminal plasma which activates the sAC (soluble Adenyl Cyclase) found within sperm, 
ultimately leading to increased cAMP production (Carlson, Hille and Babcock, 2007; Carrillo, 
2016). The acrosome reaction is a complex process which occurs through the binding to, and 
activation of specific receptors located on the acrosomal cap, with the zona pellucida, resulting 
in the release of hydrolytic enzymes. However, it is the presence of Ca2+ that has been shown 
to be a prerequisite for the acrosome reaction to occur (Brucker and Lipford, 1995; Breitbart 
and Spungin, 1997; Breitbart, 2002; Darszon et al., 2006). The initial influx of Ca2+ from 
extracellular stores via calcium channels in the membrane at the start of capacitation leads to 
cAMP-dependent intracellular Ca2+ increases, which causes membrane fluidity. This, along 
with an elevation of pH, culminates in acrosomal granule exocytosis (Brook et al., 1996; 
Breitbart and Spungin, 1997; Darszon et al., 2006; Correia, Michelangeli and Publicover, 
2015). 
Ramírez et al. (2009) reports that in the absence of capacitating media, low (100 nM) and 
medium (10 μM) concentrations of dopamine potentiates sperm tyrosine phosphorylation as 
well as sperm motility. However, at high (1 mM) concentrations of dopamine, in the presence 
of capacitating media, boar sperm displayed a marked decrease in tyrosine phosphorylation, 
total and progressive motility as early as 1 hour (Ramírez et al., 2009). Additionally, it was 
shown that low (100 nM) concentrations of dopamine, when incubated alongside capacitating 
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media, increased boar sperm viability significantly after 3 hours of incubation; this was 
postulated to be through D2 receptor activation. Furthermore Urra et al., (2014) substantiates 
these findings; after incubation with high (1 mM) concentrations of dopamine, total motility was 
significantly decreased as early as 1 hour (Urra et al., 2014). In the current study both total 
and progressive motility were significantly decreased from as early as 1 hour in the presence 
of the high (1 mM) concentration of dopamine. Additionally, the high concentration of dopamine 
also significantly decreased all the kinematic parameters analysed after 1 hour of incubation. 
The low (100 nM) and medium (10 μM) concentrations did not significantly affect sperm motility 
parameters. This is in accordance with results of Ramírez et al., (2009) and Urra et al., (2014). 
The viability of spermatozoa incubated with the high concentration of dopamine decreased 
after 1 hour of incubation and significantly decreased after 3 hours, however the low and 
medium concentrations of dopamine did not affect sperm viability. 
DAT was detected in both the sperm midpiece region, in the present study via IF, as well as 
the principal piece of the sperm tail. Thus, the inhibitory effects observed on motility parameters 
and viability when incubated with high concentrations of dopamine, is thought to be through 
mechanisms involving DAT. Although the viability results obtained herein do not exhibit the 
biphasic effects seen by Ramírez et al., (2009) for boar sperm,  it may still be postulated that 
the negative effects observed are occurring through dopamine uptake by DAT.  It is also 
hypothesized that the plasma membrane location of DAT in the acrosomal region of the 
spermatozoa plays a role in the premature decrease of acrosomal integrity. Bolan et al., (2007) 
reports that D2 receptors and DAT forms a complex hetero oligomer in neuronal membranes, 
but that this protein-protein interaction is not involved in the regulation of DAT. Instead D2 
receptor regulates DAT through mechanisms involving ERK 1/2 activation. In heterologous 
expression systems the activation of D2 receptors by agonists, such as dopamine, induces 
phosphorylation of ERK1/2. This therefore upregulates DAT at the surface membrane, allowing 
a greater number of transporters to be available to translocate dopamine into the cell (Brami-
Cherrier et al., 2002; Bolan et al., 2007).  It is hypothesized that the continued activation of D2 
receptors by dopamine results in the acquisition of more DATs to the surface membrane, 
thereby allowing the influx of a greater amount of dopamine into the spermatozoa. 
High levels of dopamine are known to be toxic in vitro and in vivo and therefore the cytosolic 
accumulation of dopamine through DAT or the enzymatic degradation of dopamine 
consequently causes sperm motility, viability and acrosomal integrity to decrease (Berman and 
Hastings, 2001; Ramírez et al., 2009). The presence of MAO has been established in both 
human and equine sperm (Dragatsis, Levine and Zeitlin, 2000; Urra, 2012). As seen in 
neuronal cells, the oxidation of dopamine (either intracellularly or extracellularly) via MAO 
(Monoamine Oxidase) leads to an accumulation of reactive oxygen species (ROS) such as 
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H2O2 and DOPAL which may lead to mitochondrial damage or the oxidation of membrane lipids 
eventually leading to cell death (apoptosis) (Li et al., 2001). Oxidative stress caused by the 
accumulation of ROS in spermatozoa is considered to be the major contributing factor in 
limiting sperm functional capacities (Ramírez-Reveco et al., 2017). ROS is shown to be 
beneficial to spermatozoa in low concentrations, by stimulating capacitation and acrosome 
reactions (Lamirande and Gagnon, 1993; Griveau and Le Lannou, 1997; Du Plessis, 2016). 
However, high concentrations of ROS in spermatozoa leads to sperm pathology via ATP 
depletion, leading to DNA damage, lipid peroxidation and loss of motility, viability, and 
induction of the premature acrosome reaction (Bansal and Bilaspuri, 2011; Du Plessis, 2016). 
Thus, through increased dopamine uptake by DAT, spermatozoa produce excess ROS and 
can subsequently have lower sperm parameters. 
Considering that catecholamines are present throughout both the female and the male 
reproductive tracts and that sperm express a catecholaminergic phenotype, it is highly likely 
that they fulfil some role in sperm functionality and reproductive physiology. As previously 
mentioned, mammalian oviductal regions differentially express catecholamines, and in 
addition, the concentration of catecholamines in these regions are controlled by the different 
stages of the oestrous cycle (Helm et al., 1982; Chaud et al., 1983; Khatchadourian et al., 
1987; Kotwica et al., 2003). Therefore, since high concentrations of dopamine decreases 
motility parameters, it could be presumed the mammalian oviduct preferentially selects the 
best sperm by immobilizing them, at the correct period of time i.e., ovulation (Urra et al., 2014).  
In summary  the study demonstrated that human sperm express DAT on their membranes and 
that dopamine elicits a dose-dependent effect on functional sperm parameters including, total 
motility, progressive motility, kinematics, viability, and acrosome reaction. Therefore, we 
postulate that in  humans dopamine is a physiological modulator of important sperm functions 
and thus ultimately involved in the control of in vivo fertilization. 






Multiple lines of evidence clearly support the presence of a dopaminergic phenotype in the 
reproductive system of mammals such as humans. Dopamine has been shown to modulate 
reproductive parameters through mechanisms not fully understood. Functional studies in 
animals, suggest DAT and DRD2 play a role in sperm functions such as capacitation, motility 
parameters and acrosome reaction. The identification of DAT on human sperm membranes 
adds to the current understanding of dopamine modulation within the reproductive system. It 
is evident that in human sperm D2 receptors are present by the effects observed upon 
stimulation with low doses of dopamine. The biphasic effect observed upon incubation with 
high doses of dopamine can now be explained by the presence of DAT on human sperm 
membranes. Considering that catecholamines are located throughout the entire passage of 
sperm along the male and female reproductive tracts it crucial to understand the role these 
catecholamines play in modulating reproductive capacities. Understanding the molecular 
events through which sperm function is key to understanding fertilization. Dopamine was found 
to modulate sperm functional parameters and can therefore be regarded as a physiological 
modulator of in vivo fertilization.  
 
Limitations 
• Due to the Covid-19 pandemic and accompanying lockdown restrictions, time 
constraints were a major limitation in this study. Due to this, experiments could not be 
repeated to confirm or disprove unexpected results. 
• Covid-19 safety protocols greatly impacted on the number of donors the study was able 
to gather. Only 5 donors were able to donate for the WB analysis to reach n=24. This 
could be a limitation as the samples were pooled together. Therefore, a lack of 
variability within the sperm samples could possibly limit protein expression.  
• We suspect the sample size of 24 also proved problematic for the WB analyses, as the 
protein content was extremely low for sperm compared to the brain controls, even 
though equal protein loading took place, therefore the protein bands appear very faintly 
on the membrane. 
 




• An antibody with a high specificity may be utilized in future experiments or adjust the 
current antibody’s concentration. 
• The blocking step in the IF protocol may need to be adjusted. The current protocol used 
a 10% FBS blocking buffer for 40 minutes, this may need to be adjusted by increasing 
the blocking buffer concentration or incubating for a longer period in blocking buffer, in 
order to block non-specific sites. 
• Functionality assays need to be performed to confirm that DAT in human spermatozoa 
is a functional protein. This may be done with the specific DAT inhibitor, Vanorexin. 
• Future studies should confirm the presence of other monoamine transporters such as 
NET and SERT on human sperm membranes since they play a role in dopamine 
uptake. 
• Considering that a DAT inhibitor may reverse the negative effects of high doses of 
dopamine and be protective to sperm, future studies could investigate the effects of 
psychostimulants such as Ritalin (a known DAT inhibitor) on sperm parameters. 
• Future studies could investigate whether a signalling complex exits between human 
dopamine receptors and transporters. 
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Preparation of buffers 
• PBS (Control diluent) 
10 mL Stock PBS (10X) + 90 mL dH2O = 100 mL PBS (1X) 
 
• Wash Buffer- 1%BSA-PBS 
1g BSA + 100 mL PBS = 1% BSA-PBS 
 
• Permeabilization buffer- 5% BSA-PBS, 0.3% Triton X-100 
5g BSA + 100 mL PBS = 100 mL 5% BSA-PBS  
90700 μL 5% BSA-PBS + 300 μL Triton X-100 = 100 mL 5% BSA-PBS, 0.3% Triton X-
100 
 
• Running Buffer (10X Stock) 
60.6g Tris + 288g Glycine + 20g SDS + 2 L dH2O = 2 L Running buffer (10X Stock) 
100 mL (10X Stock) + 900 mL = 1 L Running buffer (working solution) 
 
• Transfer Buffer  
6.06g Tris + 28.83g Glycine + 1600 mL dH2O = 1.6 L Transfer Buffer 
1.6 L + 400 mL Methanol (20%) = 2 L Transfer Buffer  
 
• TBS (10X Stock) 
48.4g Tris + 160g NaCl + 1500 mL dH2O = 1.5 L TBS (10X Stock) 
pH with 1 M HCl to pH 7.6 and top up to 2 L= 2 L TBS (10X Stock) 
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• TBS-Tween (working solution) 
100 mL (10X Stock TBS) + 900 mL dH2O + 1 mL Tween = 1 L TBS-Tween 
 
• Blocking Buffer- 5% Milk TBS-Tween 
5 mL long-life milk + 95 mL TBS-Tween = 100 mL 5% Milk TBS-Tween 
 
• Antibody diluent- 5% BSA-TBS-Tween 
5g BSA + 100 mL TBS-Tween = 100 mL 5% BSA-TBS-Tween 
 
Dilution of Dopamine Hydrochloride 
Step 1: 5 mg + 1 mL PBS = 5 mg/mL (1 mL) (STOCK 1) 
Step 2: C1  x  V1  =  C2  x  V2 
  (5 mg/mL) x (V1) = (1 mg/mL) x (1 mL) 
    (V1) = 0.2 mL 
    (V1) = 200 μL 
    200 μL (STOCK 1) + 800 μL PBS = 1 mg/mL (1 mL) (STOCK 2) 
Step 3:  C1  x  V1  =  C2  x  V2 
  (1 mg/mL) x (V1) = (0.1 mg/mL) x (1 mL) 
    (V1) = 0.1 mL 
    (V1) = 100 μL 
    100 μL (STOCK 2) + 900 μL PBS = 0.1 mg/mL (1 mL) (STOCK 3) 
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Step 4:  C1  x  V1  =  C2  x  V2 
  (0.1 mg/mL) x (V1) = (0.01 mg/mL) x (1 mL) 
    (V1) = 0.1 mL 
    (V1) = 100 μL 
    100 μL (STOCK 3) + 900 μL PBS = 0.01 mg/mL (1 mL) (STOCK 4) 
Step 5:  C1  x  V1  =  C2  x  V2 
  (0.01 mg/mL) x (V1) = (0.001 mg/mL) x (1 mL) 
    (V1) = 0.1 mL 
    (V1) = 100 μL 
    100 μL (STOCK 4) + 900 μL PBS = 0.001 mg/mL (1 mL) (STOCK 5) 
 
Preparation of Dopamine Concentrations 
Final Treatment Concentrations: 
a. 1 mM 
b. 10 μM 
c. 100 nM 
Molecular Weight (MW) of Dopamine = 189.64 g/mol 
Convert Molar to mg/mL 
a. 189.64 𝑔/𝑚𝑜𝑙 𝑥 (1 𝑥 10−3) = 0.18964  
0.18964
1000
 = 1.8964 𝑥 10−4 
1.8964 𝑥 10−4
0.001 𝑚𝐿




b.  189.64 𝑔/𝑚𝑜𝑙 𝑥 (10 𝑥 10−6) = 1.8964 𝑥 10−3 





 = 1.8964 𝑥 10−6 
1.8964 𝑥 10−6
0.001 𝑚𝐿
 = 1.8964 𝑥 10−3𝑚𝑔/𝑚𝐿  
 
c. 189.64 𝑔/𝑚𝑜𝑙 𝑥 (100 𝑥 10−9) = 1.8964 𝑥 10−5 
1.8964 𝑥 10−5
1000
 =  1.8964 𝑥 10−8 
1.8964 𝑥 10−8
0.001 𝑚𝐿
 = 1.8964 𝑥 10−5 𝑚𝑔/𝑚𝐿 
 
 























































BSA Standards for protein concentration determination 
Diluted BSA (μL) OD (nm) Mean OD (nm) Protein (μg/mL) 




















BSA Standard curve- generated from the OD readings and the protein concentrations 
of the diluted BSA standards. 
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